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1 Summary 
1.1 Zusammenfassung 
Voraussetzung für eine valide klinische Studie sind umfassende, lückenlose, schrift-
lich niedergelegte Rahmenbedingungen. Bedingt durch die Vielzahl experimen-
teller, ethischer und juristischer Anforderungen genügen viele Studienprotokolle den 
GCP (Good Clinical Practice) Mindestanforderungen nicht. 
Im Rahmen dieser Arbeit konnten alle Erfordernisse zur Generierung eines 
Studienprotokolls entsprechend den Mindestanforderungen der GCP erstmals 
vollständig in Software übertragen werden. Die Software basiert auf dem SIOPE 
(European Society of Pediatric Oncology) Template. Es lässt sich sehr einfach an 
individuelle Benutzeranforderungen und verschiedene Gebiete klinischer For-
schung anpassen. Die Software unterstützt sowohl Single- wie auch Multicenter-
Studien und ist in der Lage, mehrsprachige Protokolle zu generieren. Durch eine 
fehlertolerante, grafische Benutzeroberfläche und umfangreiche Hilfe-Funktionen 
können auch unerfahrene Anwender perfekte Studienprotokolle erstellen. Das 
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Programm ist Web-basiert, es ermöglicht simultanen Zugriff mehrerer Anwender 
und alle Daten stehen den autorisierten Benutzern sofort zur Verfügung. Das fertige 
Protokoll ist online verfügbar und kann als PDF ausgedruckt werden. 
Anwenderseitig ist lediglich ein Laptop/PC, ein handelsüblicher Web Browser und 
Internetzugang erforderlich.  
Ein besonderes Augenmerk wurde auf Datensicherheit, Zugriffskontrolle und Audit 
Trail gelegt, welche lückenlos gewährleistet sind. Die Software ist in ObTiMA 
(Ontology based Trial Management Application) integriert. 
 
 
1.2 Summary 
Only a complete and very comprehensive protocol enables a valid clinical study. 
Due to the highly diverse experimental, ethical and legal requirements many proto-
cols do not meet the GCP (Good Clinical Practice) standard. 
Through this work all requirements could completely be mapped in software for the 
first time. The program is based on the SIOPE (European Society of Pediatric 
Oncology) template and it is also easily extendible and adaptable to any other area 
of clinical research. The software supports single- and multicenter studies and 
generates multilingual protocols. Even inexperienced users can generate a perfect 
study protocol guided by a failure preventing graphical user interface and a highly 
elaborated help system. The program is web based and supports simultaneous use 
by multiple persons. All data entered are immediately available for all authorized 
users and the protocol can be printed out at any location.  There is no installation or 
maintenance work on the part of user required, just a PC or laptop, internet access 
and a common web browser is necessary for protocol generation. 
Access and version control, personnel data protection and audit trail are seamlessly 
ensured. The software is integrated in ObTiMA (Ontology based Trial Management 
Application).  
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2 Introduction 
Clinical studies are conducted to generate evidence-based data to support drug 
development up to market approval and thus establish new therapies. The legal 
environment has rapidly evolved throughout the recent decades and today there are 
plenty of statutory provisions worldwide implemented. Study design, execution and 
documentation are subjects to these detailed regulations. Although a certain degree 
of standardization has been reached, there are still differences with regard to 
national legislation. The situation is less confusing within the EU as there are EU 
Directives dealing with this topic.  
Basis of any study is a protocol that defines any detail of the clinical trial. This 
reaches from objectives through execution and evaluation to documentation. To 
meet this objective, many details must be addressed. Among those there are 
purpose and ethology, organization, trial population, personnel involved, schedule 
for monitoring, evaluation criteria, data integrity, safety of individuals affected and 
many more. In addition there might be a need for multilingual protocols and in single 
and multi-center trials one unique set of data and version control must be ensured. 
In addition amendments of protocols need to be handled according to GCP (Good 
Clinical Practice) criteria.  
It is also important to remember that statutory requirements must be complied in 
detail. Even minor deviations might lead to invalid or doubtful study results. In 
addition, there are plenty of highly sensitive personal data that must be protected 
against misuse. As of today, all these requirements are mainly met by very 
comprehensive and elaborated paper based documentation. Despite of all efforts, 
a lack of consistency or gaps in the protocols led to unnecessary high cost or even 
repetition of a complete study.  
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2.1 Evolution of Study Protocols 
The current state of the art study protocols are very extensive and highly elaborated. 
They represent a comprehensive and precise instruction of the study and all study 
related matters. This is required to ensure reproducibility and integrity of the trial 
results. The current format has only evolved since a few decades.  
The first medical studies were performed without any systematic planning and 
results were achieved by chance.  One of these very early studies was performed 
in 1537 by the French surgeon Ambroise Paré. He treated wounded soldiers with 
boiling oil, which was the “gold standard” at this time. When he ran out of oil he 
utilized a mixture of egg yolk, rose oil and turpentine to cover the open wounds. 
Healing was much faster and issues as infects and others were significantly reduced 
compared to the previous treatment [1]. 
It took approximately another hundred years until natural science in the today sense 
started to evolve and systematic investigations became more and more applied to 
problem solving. The first known “clinical study” was performed in 1747 by James 
Lind. He was a physician in the British Royal Navy and is today known as the 
discoverer of the scorbutic therapy. On the sailing vessel HMS Salisbury he was 
confronted with 12 sailors being ill with scurvy. Each two of them received well 
defined but different kind of food. Based on this trial he draw the conclusion that 
oranges and citrons are the most effective scurvy therapy [2]. 
It took another hundred years until understanding of clinical studies and natural 
science methods evolved to a degree that some elements of current standard 
occurred in trials. First time placebo controlled, randomized double blind studies 
were applied in the beginning of the 19th century to generate medical data [3]. 
However, at this time there have not been any rules and regulations with regard to 
safe and human study execution. The first ethical codex addressing this issue, the 
Berlin Codex, was set up in the year 1900. It was initiated by press publication of 
several inhuman studies. Much later, the more comprehensive “Reichsrund-
schreiben 1931” replaced the Berlin Codex [4]. All this progress was lost during the 
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Second World War [5] and detainees, disabled people and prisoners of war have 
been misused for medical experiments [6]. 
Triggered by these shocking incidents the first worldwide recognized codex was 
issued in 1947. It was included in the verdicts against National Socialistic physicians 
in the Nuremberg Trials [7]. This Codex comprised of 10 paragraphs codifying 
human rights and voluntary study participation. It gave priority to physical and 
psychological integrity over all other considerations [8].  A closer look reveals close 
links to the “Reichsrundschreiben 1931” [5]. 
Based on the Nuremberg Codex the Helsinki Declaration was issued by the World 
Medical Association in 1964. The Helsinki Declaration is much more detailed than 
its predecessors. In addition to the human rights, guidelines are included concerning 
risk assessments, minimal scientific requirements, necessity of a research protocol, 
vote of an Ethical Committee, the patient information, the “Informed Consent” and 
some more [9]. This guideline is still accepted all over the Western Hemisphere and 
many other rules and regulations refer to it  [10]. The World Medical Association has 
regularly updated the Helsinki Declaration and the last version was issued at the 
64th WMA General Assembly in Fortaleza, Brazil, in October 2013. 
The FDA1 conducted the first transcription of this guideline into a national law, the 
“National Research Act”, in 1974. Among others, this was triggered by the 
thalidomide scandal  [11]. 
In context with the international harmonization of rules, regulations and guidelines 
among the USA, Australia, Japan and Europe, the ICH GCP Guideline [12] 
(International Conference on Harmonisation Good Clinical Practice) was issued in 
1996 [13]. Unlike the Declaration of Helsinki, the ICH GCP Guideline gives a clear 
and detailed guidance on preparation, execution and documentation of a study. A 
list of requirements concerning a study protocol is given in chapter 6. It is important 
to keep in mind that ICH GCP and the Helsinki Declaration are guidelines only, 
which represent “current state of research”, but they are no legally binding 
jurisdiction. Thus, the guidelines need to be transposed into national law. For the 
                                            
1 U.S. Food and Drug Administration 
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European Union this was done by the EU Directives 2001/20/EG (Clinical Trials 
Directive) [14] and 2005/28/EC (Good Clinical Practice Directive) [15]. In 
accordance to the EU regulations, these directives were implemented in German 
law by the 12th novel of the German Drug Law (“Arzneimittelgesetz”, [16])  and the 
GCP-Decree (“Verordnung über die Anwendung der Guten Klinischen Praxis bei 
der Durchführung von klinischen Prüfungen mit Arzneimitteln zur Anwendung am 
Menschen“, [17]), [18],( [19], pp. 13-17).  
All international Pharmaceutical Companies build on the ICH GCP Guideline that is 
overlapping more than 90% with national laws in US, Europe and Japan  
( [19], p. 39).  
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2.2 Necessity of Study Protocols 
Regarding the necessity of study protocols within the European Union, one has to 
differentiate between two types of studies. The first type is the Clinical Study, the 
other is the Non-Interventional Study. Definitions of both are given in the 
2001/20/EG Clinical Trials Directive. 
“‘Clinical Trial’: Any investigation in human subjects intended to discover or 
verify the clinical, pharmacological and/or other pharmacodynamic effects of 
one or more investigational medicinal product(s), and/or to identify any 
adverse reactions to one or more investigational medicinal product(s) and/or 
to study absorption, distribution, metabolism and excretion of one or more 
investigational medicinal product(s) with the object of ascertaining its (their) 
safety and/or efficacy.“ ( [14], Article 2(a)) 
“‘Non-Interventional Trial’: a study where the medicinal product(s) is (are) 
prescribed in the usual manner in accordance with the terms of the marketing 
authorisation. The assignment of the patient to a particular therapeutic 
strategy is not decided in advance by a trial protocol but falls within current 
practice and the prescription of the medicine is clearly separated from the 
decision to include the patient in the study. No additional diagnostic or 
monitoring procedures shall be applied to the patients and epidemiological 
methods shall be used for the analysis of collected data.”  
( [14], Article 2(b)) 
A study protocol is only mandatory for clinical trials. The initiator of the study must 
set it up and it must cover many different subjects. Mandatory subjects are goals 
and objectives, methodology, study population, inclusion and exclusion criteria, risk 
assessment, statistical methods, conflicts of interest and others. The final protocol 
must be complete and comprehensive to give precise instructions for execution and 
evaluation of a study. Sponsors and scientists must find a detailed guidance how to 
act. Participants, the Ethical Committee and the Review Boards must have the 
opportunity to unequivocally understand any aspect of the study and there must be 
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no room for individual interpretation. A precise description is a prerequisite for 
reproducibility of the trial and traceability of study conclusions by the reviewer.  
There are more reasons for this requirement. A precise and detailed protocol avoids 
amendments of the finalized and approved document. If anything needs to be 
modified or supplemented at this stage or if a CRF (Case Report Form) requires 
additional data, the protocol must be updated and dependent on the impact of the 
change it might need re-approval by the supervising authorities ( [17], §10 Nach-
trägliche Änderungen). Finally, unidentified elements or gaps might jeopardize the 
entire study results.2  
The required content of a study protocol has been specified first time by just one 
single paragraph in Article 22 of the Declaration of Helsinki. Today it is required by 
Article 2(a) of the Directive 2001/20/EG (Clinical Trials Directive) of the European 
Union. However, in this Directive still there is only a brief definition, leaving the 
applicants some room for interpretation: 
 
„‘Protocol’: a document that describes the objective(s), design, 
methodology, statistical considerations and organization of a trial. The term 
protocol refers to the protocol, successive versions of the protocol and 
protocol amendments.“ ( [14], Article 2(h)) 
 
Meanwhile there are many other documents and guidelines available, which give 
additional guidance concerning protocols. Among these there is chapter 6 of the 
ICH GCP Guideline, which is a very valuable supplementation of the Declaration of 
Helsinki. This will be described in chapter 2.4.3 Most widely used Guidelines.  
In order to initiate a clinical study, the protocol must be completed. Only based on 
the protocol and some supporting documents the study can be endorsed by the 
supervising agency and an ethical committee ( [17], §7 Antragstellung). 
                                            
2 Details see Chapter 2.3 Potential Issues with Study Protocols 
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2.3 Potential Issues with Study Protocols 
Study protocols are not only required to register and execute clinical trials, but they 
affect the scientific validity of published reports as well. Since many details need to 
be taken into account and there is a lack of clarity with some guidelines, rather 
frequently insufficient protocols have been used. There are many research papers 
and review articles dealing with this issue. To identify potential discrepancies with 
regard to protocols and published study results, experienced scientists have 
reviewed publications. With a high proportion of clinical trials, a bias has been 
identified between the protocol, the reporting and execution of the clinical study. 
There have not been just one but several critical points causing issues  [20], [21], 
[22], [23]. 
The following example, taken from a study performed by Julie Pildal et al.  
“Comparison of descriptions of allocation concealment in trial protocols and the 
published reports: cohort study”, illustrates this statement. The authors reviewed 
102 clinical studies, which have been approved in 1994/95 by the Ethical Committee 
of Copenhagen and Frederiksberg [24]. 
Objective of the review was the comparison of trial protocols and corresponding 
publications with regard to an adequate allocation concealment of randomized 
clinical trials. Depending on the evaluation criteria deviations have been identified 
with 83 to 96 out of the 102 studies. Only 15 to 20 gave a distinct description of the 
allocation concealment. In addition there have been discrepancies between the 
protocols and the publications. In the majority of all cases, these discrepancies were 
either not or at least not sufficiently explained.  
The authors concluded that these studies overestimated the treatment effect by 20 
to 30%:   
„Our results make it reasonable to assume that the empirical surveys, which 
show a 20-30% exaggeration of the treatment effect for trial publications with 
unclear or inadequate allocation concealment, included some trials with 
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allocation concealment that was adequately carried out but insufficiently 
reported.” [24] 
Although the reviewed studies have been initiated in 1994/95, there is no doubt that 
issues continue until today. Tammy Hoffmann et al. reviewed 137 publications dated 
from 2009 with regard to the description of the applied interventions. Only 39% of 
these met the criteria of an adequate description. Root causes might have been 
vague guidelines or lacking protocol information. The protocol constituents have 
been either badly or not defined at all. Based on these facts the authors draw 
another conclusion: 
„ If trial reports do not have a sufficient description of interventions, other 
researchers cannot build on the findings, and clinicians and patients cannot 
reliably implement useful interventions. Improvement will require action by 
funders, researchers and publishers, aided by long term repositories of 
materials linked to publications.” [25] 
Inadequate descriptions of protocol items have been confirmed by another recent 
review. There were failures found regarding the patient-reported outcome and these 
could be traced back to the fact, that the patient-reported outcome assessment 
guidelines were inconsistent and difficult to access  [26]. 
Even reporting deficiencies, which seem to be negligible, should not be under-
estimated. If “ghost writers” are utilized but not revealed, it cannot be excluded that 
a conflict of interest affects transparency and significance of the study. An 
investigation, performed in 2007, indicated that these problems occurred in a 
significant number of studies sponsored by Pharmaceutical Industry  [27]. 
All this issues are even more severe as they do not only affect a single study but 
might lead to wrong information appearing in scientific literature available to 
healthcare professionals  [28]. 
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In accordance to EQUATOR network (Enhancing the QUAlity and Transparency Of 
health Research)3 the identified problems are summarized in a paper published in 
BMC Med in 2010 [29] giving the following list: 
 Non-reporting or delayed reporting of entire studies 
 Incomplete reporting of the study in relation to study findings  
 The omission of crucial information in the description of research methods 
and interventions 
 Omissions or misinterpretation of results in abstracts  
 Inadequate or distorted reporting of harms 
 Confusing or misleading presentations of results, data and graphs 
2.4 Guidelines 
During the recent years, many guidelines and protocol templates have been 
published to improve quality of study protocols. These documents list items, propose 
concrete protocol structure and give guidance to authors how to set up a state of 
the art protocol.  
 Trial Registration 
The Declaration of Helsinki requires official registration of any clinical trial with a 
study register. Within EU it is stipulated by the Directive 2001/20/EC that any clinical 
study being performed within the EU must be registered in the EudraCT (European 
Union Drug Regulating Authorities Clinical Trials) database [30]. This registration is 
mandatory and without a clinical study should not be carried out. In addition to 
EudraCT there are several other organizations available for registration. Among 
those there are the WHO (World Health Organization) and the U.S. FDA (Food and 
Drug Administration of the USA).   
There are many very valid reasons for study registration. Scientists and patients can 
easily get an overview over current research and the publication bias is significantly 
                                            
3 Description see Chapter 2.4.3.2 EQUATOR 
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reduced. Studies with unexpected or undesirable outcome cannot be excluded from 
publication [31], they must be made public. As important, the registration enforces 
standardization and compliance to the ethical standards. This is effectuated by the 
„minimal dataset“ required to register the study/protocol with a study register. The 
minimal dataset required for EudraCT registration is defined in the document “CT 
5.2 EudraCT core data set” [32]. However it is important to know, that this data set 
covers minimal standards only. It is not sufficient to set up a protocol just based on 
the above referenced document. To generate a complete and comprehensive study 
protocol it is essential to consider additional guidelines.  
 Trial funding - Horizon 2020 
A basic study data set is not only required for trial registration but it is a prerequisite 
for any financial support of public and private sponsors. One of the most impactful 
funding programs is Horizon 2020 [33]. This largest subsidiary program of the 
European Union is intended to promote science and innovation with 80 billion Euro 
in the period 2014 to 2020.    
In order to get access to this program the applicant must provide comprehensive 
documentation with regard to objectives, methodology and financials of a clinical 
trial. In September 2015, a template has been issued „Template for essential 
information to be provided for proposals including clinical trials / studies / investiga-
tions“ [34], which precisely stipulates the requested data. Many of these are identical 
with those required for study registration.   
„For each clinical study performed within the scope of the proposal, information on 
the issues listed below should be provided, compiled into one single document per 
proposal based on this template. Each section must be shortly and concisely 
described. In case one or more issues do not apply to a particular study, please 
briefly explain/justify.” [34] 
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 Most widely used Guidelines 
Meanwhile there are plenty of guidelines available. Many organizations and 
enterprises have issued proprietary guidelines  [35], [36], [37], [38], [39], [40], [41]. 
There are many common elements among these guidelines but there are significant 
differences as well. Some of the guidelines are incomplete, and several important 
items are not included at all. Another widespread deficiency is missing explanation 
in relation to guideline development and evidence of items is not always given [42]. 
There are some state of the art frequently used and international accepted 
guidelines available. These are described below. 
2.4.3.1 ICH GCP Guideline 
The ICH GCP (International Committee on Harmonization of Good Clinical Practice) 
Guideline was developed by an international work group and it is accepted by the 
USA, Australia, Japan and the EU. In paragraph 6 of this guideline 16 chapters are 
given concerning mandatory subjects of a study protocol. The subject of each of the 
chapters is precisely stipulated. The guideline sets a standard for patient protection 
and data integrity ( [19], p. 39). The 16 chapters are as follows:  
 
1.  General Information 
2.  Background Information 
3.  Trial Objectives and Purpose 
4.  Trial Design 
5.  Selection and Withdrawal of Subjects 
6.  Treatment of Subjects 
7.  Assessment of Efficacy 
8.  Assessment of Safety 
9.  Statistics 
10.  Direct Access to Source Data/Documents 
11.  Quality Control and Quality Assurance 
12.  Ethics 
13.  Data Handling and Record Keeping 
14.  Financing and Insurance 
15.  Publication Policy 
16.  Supplements 
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2.4.3.2 EQUATOR 
The EQUATOR (Enhancing the QUAlity and Transparency Of Health Research) 
network was founded in 2008. It represents an initiative of international scientists 
with exceptional expertise concerning test methodology, reporting and publication. 
Objective of the network is improvement of scientific reporting by promotion of highly 
precise and transparent guidelines. To set a standard, many of the existing 
guidelines were reviewed and prototypes were selected [29].  Some of the best in 
class guidelines are given in Figure 1. These and some more are accessible at the 
EQUATOR network website [43]. As the work continues it is recommended to 
repeatedly access the website. 
The most relevant EQUATOR recommendations concerning randomized clinical 
trials are presented in the next three chapters.  
 CONSORT Statement 
The CONSORT Statement (Consolidated Standards of Reporting Trials, [44]) is 
frequently utilized and widely accepted [45]. This guideline was published first time 
Figure 1: Best in Class Guidelines, recommended by EQUATOR  [43] 
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in 1996 [46]. Since then it was continuously improved and new revisions were 
released in 2001 [47] and 2010 [45]. Essence of the CONSORT Statement is a set 
of minimal requirements concerning reporting and publication of randomized clinical 
trials. The current version provides a checklist with 25 items and a flow chart. This 
checklist can be downloaded from the CONSORT Statement website and there are 
detailed explanations and examples given. It was proven that utilization of the 
CONSORT checklist significantly enhances quality of trial reports [48]. However, 
there is still a need for improvements. Despite the CONSORT Statement there are 
still gaps and deficiencies in a significant number of reports. It can be assumed that 
the CONSORT Statement was not used or has not been fully understood or 
misinterpreted by the authors [49]. 
 SPIRIT 
The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials, 
[50]) initiative was founded in 2007 and the first result was published in 2013.  This 
guideline is applicable for study protocols of randomized clinical trials and it consists 
of 33 items [51]. These items define the minimal protocol standard and they were 
selected based on expert interviews [52]. Several of these items have been taken 
over word by word from the CONSORT 2010 Statement [53]. By analogy with the 
CONSORT Statement, explanations are provided for each item and examples are 
given [54]. 
 TIDieR 
Despite SPIRIT and CONSORT Statement, interventions in protocols and reports 
are often poorly described. To improve this issue the TIDieR (Template for 
Intervention Description and Replication) was published in 2014. It includes a 33 
items list which should be used in extension to the CONSORT and SPIRIT 
checklists. The TIDieR documents can be downloaded from the Equator Network 
homepage [55], [56]. 
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2.4.3.3 CDISC 
The CDISC (Clinical Data Interchange Standards Consortium) is a global non-profit 
organization. This organization aims to establish platform independent electronic 
data models to record, transmit and publish clinical study data [57]. 
The CDISC has released several data models concerning electronic storage and 
data transfer in the XML4 format. The FDA accepts these standards and study data 
can be submitted in this format [58]. 
One of the models developed by the CDISC is the Operational Data Model (ODM). 
The first version was issued in 1999. CRFs (Case Report Forms) were the focus of 
this edition. Since then some data fields have been attached to enable electronic 
storage of clinical study protocols but this still does not cover the complete protocol. 
“ODM constructs for value sets, form sections and study events may 
also provide guidance for developers of electronic data capture 
system and contribute to better data structure compatibility across 
studies. The current ODM version 1.3.2 has limited support for 
capturing full protocol and study registration data but supports case 
report form representation well (in the design phase and with patient-
level data). These limitations exist mainly because this was not the 
original use case for creating the standard.” [59] 
In 2012 the CDISC published a model, specific for study protocols, called the CDISC 
Protocol Representation Model (PRM). It was developed with assistance of the 
European Medicines Agency (EMA) and the FDA and it was designed to support 
study protocol generation and trial registration. This model covers all essential items 
of a study protocol. All over all there are 300 items included, among those there are 
“Trial Objective”, „Phase“, and “Subject Age”.   
The model is intended to provide a standardized dataset, which can be screened 
electronically. Like the ODM, data fields are not filled with running text but with 
                                            
4 XML (Extensible Markup Language): Computer language, which supports storage of hierarchical 
structured data 
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keywords. The item “degree of blind” for example is just filled with “double-blind”, 
“single-blind” or “not-blind”. 
As Figure 2 demonstrates, there is a significant difference between a “traditional” 
study protocol in the upper part and the CDISC Protocol Representation Model in 
the lower part of the figure. In the CDISC model there are just keywords left, which 
otherwise would be hidden in the text [60]. 
Figure 2: Difference between a traditional Study Protocol and the 
CDISC Protocol Representation Model [60] 
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The single items of the model are correlated by the UML diagram ( [61], p. 496). An 
excerpt of the UML diagram is shown in Figure 3. The items are framed by squares 
and the lines indicate the correlations among these. The following example is given 
to better understand the basics of the UML model. The red box „Study Conduct Sub-
Domain::StudySite“, for example, symbolizes a study site. The other boxes 
represent many other study data, among these there is the postal address of the 
study site “Study Conduct Sub-Domain::StudySiteContact“. The study site and its 
postal address are correlated. Therefore they are linked by the red line. As there is 
no direct correlation of the study site with other items (frames) in the diagram, they 
are not connected by a line. 
However, as pointed out by the authors, this concept “was found to be too technical 
for ready use by certain target audiences“ [60]. To simplify the concept, a word 
document has been issued focusing on the 30 most important items of a study 
protocol. It is very similar to the table, given in the lower part of Figure 2 and it 
Figure 3: UML Diagram of the Protocol Representation Model [103] 
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neglects the interactions among the items. Once the simplified template is populated 
with the study data, the document represents the key information of a clinical study 
[60]. 
 SIOPE Template 
In addition to the generic guidelines, which are applicable to all studies, it can be 
beneficial to have more specific guidelines which are tailor-made for a distinct field 
of research. This is specifically valid for studies concerning pediatric oncology. 
There are few patients only in different pediatric cancers and therefore it is difficult 
to obtain funding for this research as there is little pay back in this orphan drug area. 
To increase efficiency, reduce cost and bureaucratic hurdle a specific template was 
proposed for pediatric oncology. This template was developed by a cooperation of 
SIOPE (European Society of Pediatric Oncology) and the ENCCA (European 
Network of Cancer in Children and Adolescents). The template [41] is designed in 
accordance to the ICH GCP Guideline and the EU Clinical Trials Directive 
(2001/20/EC) and it entails all items necessary for clinical trials. Requirements for 
each item are thoroughly explained supporting a protocol author to achieve a perfect 
result. In addition data structure and format of a protocol are proposed as well. 
These advantages should not be underestimated as it facilitates the work of authors 
and prevents gaps in protocols. Therefore the creators of the SIOPE template 
explicitly point out that modification of the protocol format should be kept to a 
minimum [62]. 
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 Current IT Tools supporting Protocol Creation 
2.4.5.1 CT Toolkit 
A first attempt of IT support for study development and protocol generation is the 
„Clinical Trials Toolkit“ [63] published by the UK National Institute of Health 
Research. 
The web based toolkit provides a route map (Figure 4) and explanations are given 
for all steps from design through execution to archiving of clinical studies. On the 
webpage of the National Institute for Health Research a user can click with the 
mouse on each station of the route map and he will be linked to another page provid-
ing detailed explanations and further readings. In the station Protocol Development 
for example, a user is referred to the SPIRIT Statement. However he is left alone 
with the transcription of the guideline to the protocol. The arrangement of the single 
stations in the route map matches the chronological order of a clinical trial. 
Figure 4: Clinical Trials Toolkit Interface [100] 
 26 
 
The toolkit differentiates between legally mandatory steps (red) and those which 
represent Good Practice (blue). The filled out circles indicate steps applicable to a 
clinical study, whereas empty circles are required for all types of studies. The toolkit 
is designed in accordance to the European Guidelines with special emphasis on the 
UK regulations.  
2.4.5.2 The Trial Protocol Tool 
Another attempt to simplify protocol generation has been published in 2006 by 
Shaun Treweek et al [64]. This tool, developed on behalf of the Practihc (Pragmatic 
Randomized Controlled Trials in HealthCare) [65] was aimed to support inexperi-
enced scientists located in low and middle income countries to generate compre-
hensive study protocols.  
The tool was issued as Microsoft Windows HTML help system, which is utilized for 
the Windows help since Windows 95. It is structured in six sections. It explains all 
essential aspects of a study and provides some protocol templates.  
Within each section, there are short paragraphs explaining the key features 
required; examples of suggested text and pointers to additional information including 
further readings and internet resources are given. Among those, there is the Consort 
Statement as well. However, there is no reference made to the EU regulations and 
the tool has not been updated since 2006. This is why more recent legislative 
developments of relevance are not addressed and some of the links point to 
obsolete documentation. 
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The trial protocol tool can be downloaded from the Practihc website and it can be 
executed offline. The user interface of the Trial Protocol Tool is displayed in Figure 
5. At the left hand side of the screen there are all available subjects listed and on 
the right hand side there is the corresponding content. 
 
 
Figure 5: User Interface of the Trial Protocol Tool 
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2.4.5.3 CDISC Protocol Wizard Demonstration Tool 
As mentioned in chapter 2.4.3.3 CDISC, a digital assistance tool has been published 
by the CDISC. The initially rather complicated concept of the PRM was reduced to 
a 30 item Word template. Alternatively to the Word template CDISC offers a web 
tool on its homepage [66]. Figure 6 displays the user interface.  
 
Figure 6: Web Tool of CDISC for the PRM [101] 
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A user can insert all required items into the provided input boxes and thereafter a 
PDF can be printed (Figure 7). This contains the key information of a study protocol 
[60]. 
2.4.5.4 The CONSORT based writing Tool 
IT support has the potential to significantly improve quality of study reports. This 
was shown by a study conducted by Caroline Barnes et al. They split up the method 
chapter of a study report into six domains: „Trial Design“, „Randomization“, 
„Blinding“, „Participants“, „Interventions“, and „Outcomes“ [67]. Thereafter they 
asked less experienced individuals to write a report based on executed study 
protocols. For three of the six domains there were online tools available, the others 
were not supported. The online tools offered lists of essential content in accordance 
to the CONSORT-Statement and in addition there were examples provided for each 
domain. 
 
Figure 7: PDF Printout of the CDISC Toolkit  [101] 
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Figure 8 displays the online tool for the domain “Blinding”. Very surprisingly, there 
has not only been a highly significant difference between the supported and non-
supported domains, but quality and completeness of the supported domains have 
even been superior to the original publications. 
“Overall, the global completeness of reporting scores for the sections written 
without the writing aid tool did not significantly differ from those of the 
published manuscripts, [...]. In contrast, the global score for completeness of 
reporting scores for the sections written with the writing aid tool were higher 
than those of the publications [...]” [67]. 
This tool was exclusively written for this study and it only covered six domains. It 
was never extended to a complete set and it is not suitable to generate complete 
protocols. 
Figure 8: Online Tool for “Blinding” Domain [67] 
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2.4.5.5 SWOG Protocol Reviewing System 
A working group led by Chunhua Wen et al. developed a tool for members of the 
SWOG (Southwest Oncology Group) [68]. This tool is web based and can be 
accessed simultaneously by several scientists. It provides a simple web editor and 
enables commenting of previously highlighted passages. The tool comprises the 
following modules [69]: 
 Electronic protocol management with version control 
 Collaborative annotation and group discussion support 
 Online protocol editing support by a rich-text web editor  
 Group and shared workspace awareness support 
The user interface of the tool is given Figure 9. On the left hand side of the screen 
there are the chapters given and on the right hand side there is the word editor. 
 
 
Figure 9: SWOG Protocol Reviewing System User Interface 
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Guiding principle for program development was the “Participatory design”. This 
innovative approach involved users into all stages of program development and 
resulted in a significantly improved usability of the program. Among others there is 
one major improvement concerning the review process. Traditionally emails were 
utilized to communicate comments and necessary protocol modifications. This was 
rather time consuming as big data packages had to be shared. In addition a 
seamless version control was difficult to achieve in case of parallel work of several 
scientists. After having identified this issue a web based program architecture was 
chosen and all participants got read/write access to one central master document. 
A screen shot of the SWOG Protocol Reviewing System is given in Figure 10. On 
the right hand side there is the current document. Highlighted in yellow there are the 
comments of other users. At the left hand side there is the discussion history, 
displaying authors and some comments [70]. 
 
Figure 10: SWOG Protocol Reviewing System 
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In 2005 Chunhua Weng published an article „Why it is hard to Support Group Work 
in Distributed Healthcare Organizations: Empirical Knowledge of the Social-
Technical Gap”. This paper describes the program development over a two years 
period and it includes user feedback. Many users appreciated the review mode. 
Others criticized an increased workload for authors as a lot of comments must be 
reviewed by all individuals involved.  
“Is it helpful to look at other people’s comments? It is sort of a double-edged 
sword. By looking at other people’s comments, you may see how other 
people phrase a comment in a better way so that you can learn. However, I 
cannot stop myself from looking at other people’s comments; therefore, I 
have to spend more than double the time on the system. I cannot get my job 
done in the limited time. Also, not every comment applies to me.” [71] 
 
Another point of criticism concerned the transcription from the electronic protocol to 
a paper-based document. Since there were no templates or other formatting aids 
given, formatting of the protocol depended on the authors. Thus quite frequently 
various sections of the protocols differed with regard to format. The limited features 
of the simple word processor contributed to this issue. All over all, the program 
offered very limited flexibility, it increased the workload for some authors and it never 
could find a wider use as it became not publicly accessible [71]. 
2.4.5.6 Miscellaneous Tool 
A number of tools intended to support scientists with regard to protocol generation 
have been developed around the year 2000. Among those there are the „Design a 
Trial” [72], “EON” [73], “DeGel” [74] and the TrialWiz [75]. Each of these programs 
is focused on specific aspects but does not support a complete protocol. The “Trial 
Protocol Tool“ (2.4.5.2 The Trial Protocol Tool) for example provides a knowledge 
database, others as EON can be utilized to convert a given paper based protocol 
into a computer readable format. Most of the tools seem to have disappeared, the 
remaining are obsolete from a technical point of view.  
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2.5 Conclusion: Current Situation 
As explicated in the previous chapters, a valid study protocol is the cornerstone of 
clinical research. It is mandatory from the ethical and scientific point of view but it is 
a legal obligation as well. A thorough execution of a valid study protocol ensures 
significance of study results, whereas failures in a protocol or failures during 
execution will jeopardize the complete study.  Despite the high importance of 
protocol integrity it has been disclosed by research that many protocols and 
corresponding studies do not meet the required standards. That is why many efforts 
have been made to improve the situation. EQUATOR and other initiatives have been 
launched and plenty of checklists have been generated. Recent research has shown 
that this has positively impacted quality of protocols and studies, however there are 
still gaps. The confusing large number of guidelines and checklists already available 
and the ongoing work to extend these and generate new proprietary guidelines, give 
a clear evidence of limitation of traditional tools in this highly complex matter.  
As described above there are just a few tools, which provide help for protocol 
generation and none of these tools support preparation of a complete protocol. 
Some databases such as the CT Toolkit and the Trial Protocol Tool provide 
comprehensive information but a user is left alone with regard to wording and format 
of the protocol.  
Other tools such as the CDISC Protocol Wizard Demonstration Tool provides an 
online input mask, based on the 30 most important study protocol items. At the end 
of the process, a PDF listing of these items can be printed out. This is a good 
summary, but it cannot substitute an executable study protocol. 
The SWOG Protocol Reviewing System provides a simple editor and a sophisticated 
review system. However user guidance, an elaborated help system and background 
information are missing, printout format is not defined and some users regard this 
program as confusingly complex.   
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2.6 Aims and Objectives 
As the current situation is not very satisfactory, it should be explored if there is an 
opportunity to support protocol generation by means of a comprehensive IT tool. A 
failure tolerant IT tool should support compilation of protocol subjects and printout 
of a complete ready to use study protocol.  
To identify a suitable basis, applicable regulations, guidelines, protocol templates 
and other supporting materials should be reviewed.  
Since legal requirements might change, it was important to design a modular 
program structure easily to adopt and extend. To eliminate any misinterpretation, it 
was required as well to incorporate background information for protocol authors. In 
addition it should be explored, if parallel and multicenter work can be supported 
without jeopardizing data protection and version control. 
The completed protocol should immediately be available in the standard PDF format 
via online transfer at any location. 
Finally, cost containment should be applied with regard to the utilized software. 
Ultimate goal of this dissertation was the creation of a low cost failure preventing IT 
solution to support even inexperienced scientists to prepare a state of the art study 
protocol.   
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3 Materials and Methods 
3.1 Input into Design 
 Protocol Template 
To establish a solid foundation for software development various protocol templates 
were reviewed. Finally the SIOPE template was chosen, as it offers several 
advantages. As described in chapter 2.4.4 the SIOPE template is very well 
elaborated and covers all items required by chapter 6 of the ICH GCP Guideline. In 
addition, this template takes European regulations into consideration which is not 
the case with these issued by the US Institutes of Health and other organizations. 
Another advantage of the SIOPE template is the clear structure and high degree of 
standardization among the different pages. Despite this, the pages are designed in 
a way that adaptions to a specific study can easily be done and a concrete page 
format is given.  
One example of the high degree of user friendliness of the SIOPE template is the 
included chapter “Trial Records”. In the very most cases the text provided in this 
chapter can be used as proposed and only minor changes must be applied. This 
design and the high degree of standardization simplifies the transcription into an IT 
solution. 
The SIOPE protocol has been developed for pediatric oncology but it is applicable 
for any trials concerning Investigational Medicinal Products (IMP). The software 
design has followed a modular approach. Therefore, it is feasible at any time to 
extend the program and offer additional sets of templates if SIOPE does not 
completely satisfy the needs.  
 Legal Framework 
To fully understand the legal provisions relating to templates and to avoid any 
pitfalls, significant work has been performed. Many discussions and interviews with 
experienced physicians and scientists were made, having had many years of 
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experience in regard to study design and execution. Very valuable information has 
been gained through these interviews and has been implemented into software 
design. In supplementation of these interviews, protocols of valid and approved 
studies have been analyzed and as a matter of course all applicable regulations 
have been checked. These are the ICH GCP Guideline, the EU Directives 
2001/20/EG (Clinical Trials Directive), the 2005/28/EC (Good Clinical Practice 
Directive) and the corresponding German Regulations, the German Drug Law 
(Arzneimittelgesetz), the Medical Device Directive (Medizinproduktgesetz) and the 
Decree concerning Good Clinical Practice in the Conduct of Clinical Trials on 
Medicinal Products for human Use (Verordnung über die Anwendung der Guten 
Klinischen Praxis bei der Durchführung von klinischen Prüfungen mit Arzneimitteln 
zur Anwendung am Menschen).   
The correct understanding of the legal framework was validated by experienced col-
leagues of the research team of the Saarland University (Saarbrücken/Homburg). 
  
 ObTiMA 
To design and code a new piece of software from the very scratch is extremely 
demanding and time consuming. It is much more economical to utilize an already 
existing environment. A first evaluation revealed the ObTiMA (Ontology-based Trial 
Management Application, [76]) study administration program as ideal platform to 
build on.  
ObTiMA is a highly innovative very flexible study administration program. It supports 
study design, data administration and supervision of clinical studies. It provides the 
capability to link a study to patients, investigators and organizations. In addition it 
offers the opportunity to process CRFs (Case Report Forms), Bio-Databases 
(pathological laboratory data) and it is capable to automatically handle and distribute 
adverse event reports. Even more there are mechanisms in place to ensure 
personal data protection and anonymization in accordance to the applicable 
regulations. Finally ObTiMA offers a mature and very well tested environment and 
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due to its modular design and the very well defined interfaces it seemed to be an 
ideal platform to build on. 
For this reason the MasterProtocol-Creator was not developed as a standalone 
program, but as extension of ObTiMA. Many of the required study data as 
personnel, investigators and organizations are available in ObTiMA and can be 
taken over by the MasterProtocol-Creator avoiding redundant data entry. In addition 
some of the established safety features as user administration and access 
management of ObTiMA can be utilized as well.  
 Design, Development and Program Structure    
Guiding principle for program design were easy learnability and ergonomic use. This 
was achieved by a graphical user interface. These characteristics and the 
adherence to legal requirements have been validated at any time of software 
development through feedback from experienced clinical physicians. In addition to 
this, an early version of the program was presented in the frame of the Second 
Summer School in Computational Oncology 2013. Highly valuable input and 
improvement ideas have been received from the experts and have been taken into 
consideration during further program evolution.  Another source of information has 
been the University internal ObTiMA developer’s conferences. A close cooperation 
with the ObTiMA developers enabled a seamless integration of the MasterProtocol-
Creator into the ObTiMA program. 
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3.2  Infrastructure 
The MasterProtocol-Creator has been written as a web server client application [77]. 
All software, data and resources are located on the server and the user (client) just 
needs a simple PC or Laptop equipped with a common web browser. The only 
additional requirement is permanent web access to the ObTiMA server. This design 
always ensures utilization of the latest program version and minimizes local 
resources in terms of hardware, software and program updates. Another benefit is 
minimization of cost. No software package needs to be purchased and installed by 
an untrained user and no complex and expensive hardware needs to be kept. Finally 
study data are highly sensitive information. The program design enables highest 
level of data protection and seamless data access control. 
As explained above, requirements for the user are negligible, but the program 
design is rather demanding with regard to hard- and software of the server. 
 Programm Environment 
During development and testing, the MasterProtocol-Creator was executed on a 
virtual server5. The virtual server runs the operation system Ubuntu 15.10 [78] and 
it was executed on a main frame in the computing center of the Saarland University. 
16 GB ram and 16 GB hard disc were allocated to the virtual server. Depending on 
the number of users and the frequency of access it is recommended to execute the 
finalized software package on a non-virtual, dedicated machine.    
 Server Software 
To execute ObTiMA and the MasterProtocol-Creator, various software components 
have to be available on the server.  
Web server: The web server has been an Apache-Tomcat web server, version 8 
[79]. This program is open source and provides the vast majority of the standards 
required by the Java Enterprise Edition ( [80], p. 4 ff). Therefore it includes a Servlet-
                                            
5 Virtual server: Is an artificial computer system emulated by a main frame. A main frame can run 
several virtual servers simultaneously. 
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Container ( [81], p. 1 ff), which interprets and runs ObTiMA and the MasterProtocol-
Creator. Apache-Tomcat is published under the Apache License Version 2 and can 
be freely used without jeopardizing intellectual property. The server machine was 
accessible through port 8123 via Http protocol [82]. Data transfer was encrypted 
utilizing the TLS protocol [83]. 
Database: The data have been processed by means of the PostgreSQL data base 
software which supports the majority of the SQL (Structured Query Language) 
standards ( [84], p. 1 ff). To ensure data protection, the database is only accessible 
by programs running on the server. There is no direct access feasible from the web 
except utilizing ObTiMA and the MasterProtocol-Creator. PostgreSQL has been 
selected to minimize cost, as it is open source and the PostgreSQL License 
authorizes private and commercial usage as well without any royalties. PostgreSQL 
has some significant advantages with regard to data integrity. This is achieved by 
the ACID (Atomic, Consistent, Isolated, Durable) concept. Which basically means 
that a new set of data will not be transferred into the database before the 
transmission is finalized. Incomplete set of data will be dispatched. This procedure 
prevents a corruption of the database ( [84], p.164 ff). 
Java Runtime Environment: The MasterProtocol-Creator, ObTiMA and the 
Apache Tomcat web server are written in Java. Java and Java based programs 
were selected as this computer language has several advantages. Most significant, 
Java enables object orientated programing. Each Java program consists of single 
independent modules called „objects“. Once objects have been programed they can 
be used repeatedly on various steps in the program. This reduces program coding, 
shortens the source code, simplifies bug fixing and increases readability of the 
program code. This language can be freely utilized without license cost as well. 
Because of its advantages Java is one of the most commonly used languages and 
there are plenty of libraries and programming tools available. These significantly 
reduce efforts of program writing. Finally there is a huge community which can be 
approached in case support is needed. The established Java code is a byte code  
( [85], pp. 52 - 57), thus it cannot be processed by the common operating systems. 
In order to execute the Java code an operating system specific Java runtime 
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environment is required. This software is freely available as well and to execute a 
Java program, it will be translated into binary code first by the runtime environment. 
As there are runtime environments available for various operating systems, Java 
programs are easily portable and platform independent. The runtime environment 
chosen for ObTiMA and the MasterProtocol-Editor has been Java Version 8 [86].  
The interactions between the software components described above are visualized 
in Figure 11. 
  
3.3 Development Environment 
The MasterProtocol-Creator was written in the Java development environment 
Eclipse [87], Java EE developer Version 4.5. To become independent from the web, 
a local Tomcat server was installed on the laptop utilized for programming and test 
runs. After finalizing and bug fixing, the program modules were uploaded to the web 
accessible space of Apache Subversion Server by the Tortoise SVN client [88]. 
Following this process the new modules of the MasterProtocol-Creator were merged 
with the latest ObTiMA version and a copy was stored in the Apache Tomcat 
execution folder. This enabled immediate access for other ObTiMA users to support 
a multi user testing. In addition to Eclipse, Photoshop Version 5 and Paint.net were 
used to create icons and images for the MasterProtocol-Creator. Wizard Help Texts 
and Quick Guides were written with Microsoft Word.  
Figure 11: Software Environment of the MasterProtocol-Creator 
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3.4 Program Architecture 
 Spring Framework 
As described above, the program was written in Java. To extend functionality and 
further reduce programming efforts, the Spring Framework was used. This bears 
several significant advantages. One of these, the Dependency Injection 
automatically assigns previous user defined resources and objects. The 
administration runs in the background without involvement of the programmer  
( [89], pp. 37 - 38). 
Another frequently used Spring Framework feature is the Model-View-Controller 
Concept illustrated in Figure 12. This concept was developed in 1979 [90] and 
adopted to Java in 1998 [91], called Model 2. Due to this concept, the application is 
split into three interactive components, called “Model”, “View” and “Controller”. An 
advantage of this concept is a clear separation of program logic and user interface. 
Figure 12: Model View Controller Concept 
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The Model is the entirety of the objects, e.g. the Java source code. It interacts with 
the PostgreSQL database and manages the operations. The View provides the user 
interface. It extracts data from the model and converts these into a graphical display. 
Different to the rest of the MasterProtocol-Creator, the View source code is not 
written in Java, but with JavaServer Faces [92]. This technique allows easy 
generation of websites using predefined components as check boxes and panels. 
The established webpages are interpreted by the Tomcat web server and converted 
into code, which can be displayed by the browser of the client (user).  The third 
component, the Controller, s provided by the Spring Framework and takes care of 
communication with the user and handles access control ( [93], pp. 518 – 522). 
 Hibernate Framework  
The Hibernate Framework manages the linkage of the MasterProtocol-Creator to 
the PostgreSQL data base by usage of the Object-Relation Mapping technique. This 
technique enables direct storage of Java objects in the database. A user-managed 
conversion of these objects into SQL code is not necessary. Once again this 
technique significantly reduces programming effort and supports program 
maintenance [94]. In addition the Hibernate Framework provides backup and 
version control capabilities.  
3.5 Paragraphs 
The data of the study protocol are stored in the database in several independent 
packages called paragraphs. Each of the paragraphs contains the data required by 
one chapter or subchapter of the SIOPE template. The paragraphs are merged into 
the final study protocol not before the PDF printout.  
The standard protocol consists of 34 paragraphs. These are named in accordance 
to the chapters and subchapters of the SIOPE template and contain the data 
required by the corresponding chapter. The paragraphs are stored in the order, 
which is required by the template (see Figure 14). Each paragraph can be one of 
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five types. Each type has an individual input mask and can process different data 
types (see Figure 13). 
 
Figure 13: Five different Types of Paragraphs 
Figure 14: Paragraph Order 
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In addition to the paragraphs there are 4 folders in the basic protocol. Every folder 
comprises several paragraphs with related content. This simplifies keeping an 
overview (4.2.2.2 Folders).  
However the user is not bound to a static protocol structure. The MasterProtocol-
Creator provides any freedom to generate customer specific protocols (4.2.2.3 
Customizing the Protocol). 
The separation into paragraphs has several advantages. First of all there is a highly 
transparent link to the SIOPE template. Second, integration into ObTiMA is 
significantly simplified by this data structure.  
The most frequently used paragraph is the Text-Paragraph. It provides a standard 
word processor and a protocol author can fill in any free text. Another paragraph, 
the Personal-Paragraph gets its data from the ObTiMA database and prepares lists 
of individuals associated with the trial. 
Segregation enables parallel processing. Several users can populate different 
paragraphs completely independent. Because of the web access they even do not 
need to be at the same location. This option might be utilized by a statistician who 
will probably not be located in the hospital together with a study sponsor or a 
physician supervising the study.  
Data transfer is significant faster, as just the paragraph, which will be edited, needs 
to be transferred via Internet. Despite the enormous progress of the web throughout 
the recent years a complete document including pictures would take a while until 
loaded.  
Due to the different data structure of the paragraphs, utilization of ObTiMA data is 
significantly simplified and new paragraphs can be added without affecting the 
existing ones. 
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3.6 Generation and Printout of the Study Protocol 
If all paragraphs are populated with the data required by the study, the protocol can 
be exported to a PDF file. During creation of the PDF file, the paragraphs are 
merged into one single document in accordance to the previously stored order. The 
PDF file can be printed out and serves as the study protocol. 
Each paragraph represents a separate HTML6 page. Before PDF generation, the 
single pages are merged into one HTML document. It cannot be completely 
excluded that syntax failures occur in the final HTML file. In addition some country 
specific characters as mutated vowels will be wrongly displayed in the PDF. 
Therefore the MasterProtocol-Editor was designed to apply the JTidy (Version: 
Snapshot 938) library before any conversion. This library removes all syntax errors 
and converts mutated vowels in a way that these can be displayed correctly. 
Afterwards the table of contents is generated and headers and footers are added.  
The subsequent transformation of the HTML document into the PDF format utilizes 
the Flying-Saucer library, an extension of iText 2.17 [95]. Flying-Saucer supports 
headlines, table of contents, footer and header, but is not capable to render pictures 
and diagrams embedded in the HTML source code. To manage this conversion an 
                                            
6 HTML (Hypertext Markup Language): Language to create webpages  
Figure 15: Protocol PDF Generation Process 
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extension was written. After finalizing the conversion, the generated PDF is stored 
in the PostgreSQL database. Thereafter the study protocol can be printed in PDF 
format. This format was chosen as it is independent of the operating system and 
independent of word processors. Content and formatting are not easily impacted 
during transfer, handling and printout and PDF format is widely used and accepted.  
3.7 Additional Libraries used by the Program 
PrimeFaces [96]: This open source component library offers plenty of useful items 
to extend JavaServer Faces. Many of those have been utilized to establish the user 
interface of the MasterProtocol-Creator. PrimeFaces was used in Version 5.1. 
Jsoup [97]: This library offers routines to create and modify HTML pages. It is 
frequently used by the different paragraphs to convert complete HTML pages into 
Java objects and back again. An example for a program utilizing Jsoup is the 
Personnel-Paragraph which generates user lists with data from the ObTiMA 
database. Another example is the Table of Contents-Paragraph which scans all 
other paragraphs using the headlines to create the table of contents.  
Gson [98]: Analogue to the Hibernate Framework (3.4.2 Hibernate Framework) 
Gson enables easy data transfer from Java objects to text files. These text files, in 
the widely used JSON format, are stored in the ObTiMA database. In opposite to 
Hibernate, which generates one table per object, Gson just generates one single 
text file to store all attributes of an object. The JSON transformation was applied to 
rarely used objects. This saves storage area and minimizes the size of the ObTiMA 
database. 
3.8 Software Licenses 
One objective for software development was minimization of cost. This was fully 
achieved by utilization of royalty free software and libraries, many of these open 
source code. The following software has been used: 
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Programm / Library Version License 
Apache Tomcat 8.0.26 Apache License 2.0 
PostgreSQL 9.4.4 PostgreSQL License 
Java Runtime Environment 8 Update 60 Oracle Binary Code License (BCL) 
Apache Subversion 1.9.0 Apache License 2.0 
TortoiseSVN 1.9.1 GNU General Public License 
Eclipse 4.5 Eclipse Public License 
Spring 4.1.6 Apache License 2.0 
PrimeFaces 5.2 Apache License 2.0 
Programs within the Java 
Community Process, e.g.: 
 JavaServer Faces and 
Java Servlet 
 Enterprise Edition 6 
Specification 
 different, but royalty-free licenses [99] 
Jsoup 1.8.2 MIT License 
Gson 2.3.1 Apache License 2.0 
JTidy r938 JTidy License 
Flying Saucer 9.0.9 
SNAPSHOT 
LGPL 
iText 2.1.7 LGPL 
Table 1: License Listing 
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4 Results 
The MasterProtocol-Creator was developed as an extension of the medical study 
administration program ObTiMA (Ontology-based Trial Management Application) to 
easily set up trial protocols. The MasterProtocol-Creator consists of three modules. 
These are the MasterProtocol-Wizard, the MasterProtocol-Editor and the 
MasterProtocol-Helpcenter.  
The MasterProtocol-Wizard provides all essential knowledge needed to setup a 
protocol for a clinical study. As the program is aimed towards inexperienced users, 
it includes an elaborated support system. This is based on a step-by-step guide for 
protocol preparation. Among others, it explains classification of studies, the 
registration process, gives definition of sponsors and provides access to the 
guidelines. Once a user has completed all steps, he should have an understanding 
of the applicable regulations and based on the data entered the wizard automatically 
generates a basic study protocol in accordance to the SIOPE guidelines.  
The MasterProtocol-Editor is used to customize the previously generated protocol. 
It offers various modules to utilize data already available in ObTiMA and enables 
input of other study specific data. In addition, the editor handles version 
management and offers printing and exporting features. 
The MasterProtocol-Helpcenter is accessible at any time from the MasterProtocol-
Wizard and the MasterProtocol-Editor modules. It displays help screens supporting 
usage of the other two modules and it provides many links to external websites. At 
these websites the user will find rules, regulations and further guidelines applicable 
to study protocols. 
All three modules are accessible by the user-interfaces of ObTiMA (Figure 16). The 
MasterProtocol-Creator can be started by the option “Tools” in the menu bar (Figure 
16 (1)). If the MasterProtocol-Creator is opened for the first time within an ObTiMA 
session7, a selection of all studies already available is shown (Figure 16 (2)). Now 
                                            
7 ObTiMA session: At any time a user signs in to ObTiMA a session is started. 
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one of the studies can be selected and a protocol for the study can be designed or 
a protocol, which has been generated previously, can be edited.  
If a study is chosen and the associated protocol is already available, the 
MasterProtocol-Editor will start immediately. If there is no protocol available, the 
MasterProtocol-Wizard will appear on the screen instead. 
 
 
  
Figure 16: ObTiMA User Interface, Study select Screen (2) 
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4.1  MasterProtocol-Wizard 
The MasterProtocol-Wizard provides user support to generate a novel study 
protocol. A user just needs to process every single step of the menu (Figure 17 (1)) 
and at the end he has got a lecture on the study protocols and a basic protocol will 
be generated. 
 Wizard Structure 
On the left hand side of the screen (Figure 17 (1)) is a menu. It lists all potential 
steps. Some of these are mandatory statutory provisions, others are based on 
recommendations only and there are some which just provide information. The icon 
in front of each option indicates the classification and the check at the end of the 
line indicates the status:  
 Step without icon, information only and links to web resources.  
 Orange star ( ), mandatory steps 
 Yellow exclamation mark ( ), recommended but not mandatory 
 Green check ( ), step is completed  
Figure 17: User Interface of the MasterProtocol-Wizard 
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All steps can be processed in the given or in a free order. Single steps can be 
skipped and processed later. 
On the right hand side of the screen (Figure 17 (2)) there is the Wizard space. It 
displays introductory text concerning the step selected from the menu. In addition 
there are input fields. A user is required to enter some data required to generate a 
basic, non-customized protocol. Close to the upper frame of the screen, there is the 
navigation panel (Figure 17 (3)). It displays the current step and right of it there are 
the navigation buttons. These are “Next” (step), “Previous” (step), “? Help” and 
“Exit”. By use of the “Exit” button the actual status will be saved, the Wizard will 
close and the study selection list will appear again.   
 Wizard Steps 
If one step from the menu is selected the corresponding screen opens. The step 
“Basic Trial Data” is displayed in Figure 18. 
Most of the screens include input fields. Adherent to each data field explanations 
are given concerning the data and the data format. Most pages include a section 
“further reading”. This section provides web links to homepages containing detailed 
information about the topic addressed by the data fields. On these webpages, the 
user will find rules, regulations, guidelines, tool kits and more.  
Figure 18: MasterProtocol-Wizard Step "Basic Trial Data” 
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The menu offers the following steps: 
 Introduction: Information on the wizard. In addition there is a button “Skip 
wizard” on this page. A more advanced user can click this button and will 
immediately be at the last step “Create protocol”.  
 Trial Planning: A lesson regarding trial planning principles and applicable 
guidelines of the European Union. 
 Trial within Scope: Selection of study type, interventional or non-
interventional study. An interventional study requires a SIOPE template; a 
non-interventional study can utilize an empty form (see below). 
 Basic Trial Data: Name and acronym of the study, protocol language, study 
characteristics (single or multicenter study). 
 Select participating Countries: Countries can be selected from a 
predefined list. 
 Sponsor Information: Definition and tasks of the sponsors. 
 Select Sponsors: Sponsors can be selected from a list provided by the 
ObTiMA database. Functionality equivalent to the “Personnel Paragraph” 
(4.2.2.1.3 Type Personnel-Paragraph) 
 Study Registration: Explains the process of study registration with various 
organizations, main focus on EudraCT. 
 Select participating Organizations, Select participating Investigators, 
Add miscellaneous Organizations: Generate lists. These need not to be 
completed; they can be extended at any time. 
 Protocol Signature: Identification of individuals, who have to approve (sign) 
the study (sponsors, principal investigator, statisticians and others). 
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 Create protocol (Figure 19): Two options are offered. 
o Create empty Protocol: An empty protocol template is issued. This 
option supports non interventional studies. 
o Use SIOPE Template: All previously entered data will be used to 
generate a protocol in accordance to the SIOPE template. 
 
 
  
Figure 19: Select Generic or SIOPE Protocol Template 
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4.2 MasterProtocol-Editor 
Once all requested data have been entered into the MasterProtocol-Wizard, a 
generic study protocol is available in the MasterProtocol-Editor. This protocol 
includes 34 independent parts called paragraphs. 
 Editor Structure 
A screen shot of the user interface is given in Figure 20. In the menu on the left hand 
side of the screen the paragraphs are listed (Figure 20 (1)). On the right hand side 
is the help screen (Figure 20 (2)) and in the center is the editor space (Figure 20 (3)). 
 
 
 
Figure 20: User Interface of the MasterProtocol-Editor 
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4.2.1.1 Paragraph Section  
In the basic protocol version every paragraph listed in the paragraph section (Figure 
20 (1)) has a title, e.g. “Background and Rationale” (Figure 20 (4)), in accordance 
to one of the SIOPE chapters. The user is free to change the titles and he can add 
or delete paragraphs. The icon in front of the title (Figure 20 (8)) indicates the type 
of the paragraph ( , , , , ) or folder ( ). If the user clicks on one of the items 
with the left mouse button, the input mask will appear in the editor space. Now the 
user can adopt the content to the specific study.  
If a user selects a paragraph with a click on the right mouse button a different menu 
opens (Figure 21). This menu can be used to delete, rename or move a paragraph 
up- or downwards. In addition it enables integration of additional paragraphs. The 
various options of the menu are described in 4.2.2.3 Customizing the Protocol. 
4.2.1.2 Editor Space  
The editor space is located in the center of the screen (Figure 20 (3)). If a paragraph 
is selected, all information becomes visible and can be altered. The corresponding 
editing functions are explained in the following chapters. 
Figure 21: Paragraph Edit Menu 
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The navigation bar is located above to the editor space (Figure 20 (7)). On the left 
hand side of this bar the name of the selected paragraph (Figure 20 (5)) is displayed 
and on the right hand side the extendible option menu (Figure 20 (6)) can be 
accessed. This menu is given in Figure 22. 
The single items of the Options menu are: 
 Preview Mode: Displays the PDF preview. 
 Export Protocol: Lists all available protocol versions and download links. 
 Settings: The MasterProtocol-Editor can be customized to individual users 
requirements (See chapter 4.2.6 Editor Settings). 
 Info: Displays key parameters of the current study protocol. 
 Help: Access to the MasterProtocol-Helpcenter. 
 Wizard: If the MasterProtocol-Wizard has not orderly closed before, it can be 
restarted again. 
 Exit Protocol Creation: Current protocol is saved and the editor will close. 
Other elements of the MasterProtocol-Editor navigation bar are: 
Quick Setting Menu : Several functions accessible. First the current language 
can be changed. Second, depending on the selected paragraph type, type specific 
Figure 22: Extendible Options Menu, located in the 
Navigation Bar 
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options become available. These are described below in 4.2.2.1 Types of 
Paragraphs. 
Save button : Wherever this button appears, the current protocol can be stored 
into the ObTiMA database. 
4.2.1.3 Help Section 
The help section (Figure 20 (2)) visible on the right hand side of the screen, briefly 
describes the options available in the editor space. In addition, there are links 
leading to the corresponding section of the MasterProtocol-Helpcenter. There the 
user will find an extended description of all options. A more advanced user can close 
the help section in the “Editor Settings”. This will enlarge the editor space.  
 Paragraphs 
The paragraphs are the backbone of the editor. As described above, every single 
paragraph contains one part of the protocol and each paragraph can be populated 
with data in a type specific input mask.  
4.2.2.1 Types of Paragraphs 
All over all there are five different types of paragraphs available (Figure 13). Every 
type offers different functionality. The very flexible program design enables a user 
to create additional fully customized types. However this is not guided by menus 
and therefore it is only feasible for a more advanced user. Although this extension 
is not needed to meet current legal requirements, it enables adaption of the 
MasterProtocol-Creator future needs. 
 Type Text-Paragraph 
The Text-Paragraph provides highest flexibility and therefore it is the most frequently 
used type. In the paragraph section these paragraphs are indicated by the speech 
bubble icon in front of the paragraphs titles (Figure 20 (8)). 
Basically, this paragraph is a text editor. It is comparable with Microsoft Word or 
LibreOffice Writer. A screen shot is given in Figure 23. By use of the Text-Paragraph 
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free text and tables can be edited. By drag and drop pictures in the JPEG, PNG and 
GIF format can be embedded into the text. Furthermore, the editor can handle 
Microsoft Word documents. It is even possible to set URL links to pictures available 
in the internet. In this case there is a limitation as the URL must not use SSL 
encryption (HTTPS). In addition a spellchecker with multi language support is 
available.  
Most of the editor icons offer the same functionality as the equivalent icons of the 
standard word processors. Therefore a detailed description of the functionality is not 
given in this document. In addition there are three unique icons which need 
explanation: 
  Word Icon: Transfer of Word files into the editor. 
  Full screen mode: Extends the editor space to full screen. Another click 
on the icon restores the previous view again.  
  Help Screen: Explanation for all editor icons is given. 
Like a standard word processor, e.g. Microsoft Word, the text editor is capable to 
structure voluminous documents into chapters and add headlines to each of the 
chapters. There is no limitation on the number of chapters and the headlines will 
Figure 23: Input Mask of the Text-Paragraph 
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automatically be inserted into the table of contents. This feature is unique to the 
Text-Paragraph. Other paragraphs as the Personnel-, the Amendment-Paragraph 
and the table of contents offer limited headline capabilities only. Just one headline 
per paragraph can be set by a specific option (4.2.2.1.3 Type Personnel-Paragraph). 
 Type Resources-Paragraph 
This paragraph indicated by the icon  supports importation of pictures (JPEG, 
GIF, PNG) and PDF documents. The imported documents and pictures are treated 
as separate pages. The size of the pictures can be adopted. Maximum size is one 
full DIN A4 page, minimum size is not limited. If PDF is imported size and format of 
the original file remains completely unchanged. This can be used to generate 
attachments to the study protocol, frequently utilized for the “Informed Consent”. 
The input mask of the Resources-Paragraph is shown in Figure 24. 
The option menu bar on top of the screen provides the same basic functionality as 
explained in Figure 22. In addition there is the “Upload” button . It can be used 
Figure 24: Input Mask of the Resources-Paragraph 
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to import PDF documents and pictures. Upon pressing the button, another dialog 
shown in Figure 25 appears.  
By this dialog a user can upload any file from the local drive and attach descriptive 
comments. The uploaded file appears in the “Available Files” list (Figure 24 (1)) of 
the Resource-Paragraph. If any further files are uploaded they will be attached to 
the “Available Files” list as well, but only one of these will be displayed in the 
“Selected File” area (Figure 24 (2)) and will be used by the Paragraph. This file can 
be selected in two different ways. First before uploading by setting the option “Select 
File” (Figure 25 (1)) to “yes”, second at any time by clicking on one of the files which 
are displayed in the “Available Files” list. If a file is not needed any longer it can be 
deleted from the “Available Files” list by clicking the cross button. The “Settings” 
panel (Figure 24 (3)) is only applicable to pictures. It can be determined if the picture 
should cover the complete page or just a specified area.  
  
Figure 25: Dialog for Uploading new Files 
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 Type Personnel-Paragraph 
It is mandatory to list all personnel and institutions in the study protocol, which are 
associated with the trial. The Personnel-Paragraph automatically generates these 
lists utilizing data provided by ObTiMA. If these data are modified in the ObTiMA 
database, the Personnel-Paragraph updates the previously generated lists without 
user intervention. This paragraph is indicated by the icon in the paragraph sec-
tion (Figure 20 (1)). 
  Different List Types 
All over all, the Personnel-Paragraph offers five different types of lists. Every type 
can either list individuals, organizations or both of them. The user can determine 
appearance and content of a specific list by choosing one of several templates 
available. If no template meets the expectation, a user can create additional 
completely customized templates. Figure 26 illustrates appearance of a sponsor list. 
In this example only two researchers are included in the list, but there are no 
limitations by the program to extend a list to any lengths. The completed list can be 
printed in the Portable Document Format (PDF).   
The five list types of the Personnel-Paragraph are: 
 Type 1: The “Sponsor-List” can include individuals, organizations or both of 
these. This is necessary as a sponsor can be an individual or an organization 
as well. If there are several sponsors with concurrent characteristics, they 
can be combined to groups. Group specific names can be attached to 
pinpoint roles and responsibilities. For example, all sponsors from UK can be 
combined in one group named “UK Sponsors”.  
This type enables identification of all sponsors involved into a clinical trial. 
Figure 26: Example of List Type 1: Sponsor List 
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 Type 2: The “Simple Personnel-List” comprehends individuals only. It is just 
a listing of researchers and other personnel associated with the trial. Each 
person can be linked to a specific responsibility. In Figure 27 Prof. Dr. Norbert 
Graf is indicated as “Lead Investigator” and Yvonne Braun and Dr. Holger 
Stenzhorn as ”Investigators”. The user can freely enter any responsibility and 
it is feasible to allocate one responsibility to several individuals. 
 Type 3: The “Personnel-List” is similar to the “Simple Personnel-List”.  
Contrary to the “Simple Personnel List”, this list summarizes several 
individuals into one group and allocates one single responsibility. In Figure 
28 two researchers act as investigators. In the “Simple Personnel-List” the 
title investigator would appear as often a new name is added. Thus “Simple 
Personnel-List” is an 1 : 1 allocation, the “Personnel-List” is an 1 : n allocation. 
 
 
 
Figure 27: List Type 2: Simple Personnel-List 
Figure 28: List Type 3: Personnel-List 
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 Type 4: The “Simple Organization-List” comprehends organizations only. 
Analogue to the “Simple Personnel-List”, it enables allocation of one specific 
responsibility to one specific organization (1 : 1 allocation). This type can be 
utilized to generate a listing of all institutions associated with a trial. 
 Type 5: The “Complex Organization-List” comprises organizations and the 
associated employees. Each of the organizations can be linked to a specific 
responsibility and every employee of each organization can be linked to a 
specific function within this organization. Figure 29 illustrates a “Complex 
Organization-List” with two organizations and three employees. 
  
Figure 29: List Type 5: Complex Organization-List 
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 User Interface of the Personnel-Paragraph 
All five list types can be generated by one common user interface. A screen shot is 
given in Figure 30. The input mask must be processed line by line and a user is 
guided through all steps necessary to generate a Personnel-List. In the first step the 
type can be selected from a pull down menu (Figure 30 (1)). 
 
Figure 30: Input Mask of the Personnel-Paragraph 
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In the second step the layout can be selected by clicking on the “Select” link (Figure 
30 (2)). This will open a dialog as given in Figure 31. Now all available templates for 
the specific list type are accessible. 
Each row within this dialog gives name (Figure 31 (1) e.g. “User List 2”) and preview 
(Figure 31 (2)) of one of the predefined templates. The preview provides a dummy 
view how the list will look like, if chosen. The row highlighted in yellow indicates the 
active (selected) template, which will be utilized by the Personnel-Paragraph to 
generate the list. The selection can be changed easily by clicking the “Select 
template” button (Figure 31 (3)) or by clicking on the preview image of the desired 
template on the right hand side of the dialog. This will determine the template, close 
the dialogue and the name of the selected template appears in the input mask 
((Figure 30 (3)). This setting can be revised at any time by clicking on the “Select” 
link (Figure 30 (2)) again. 
After these two steps have been completed, the list type is selected and the template 
is defined. Now a new button (Figure 30 (4)) becomes available. Depending on the 
list type, this button enables different actions. In case of the “Simple Personnel-List” 
or the “Organization-List” either persons or organizations can be added to the list. 
In case the “Personnel-List” or the “Sponsor-List” has been selected, a group will be 
Figure 31: Dialog, Select Template Type 
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created in a first step and thereafter people or organizations can be attached to the 
group.  
The following examples illustrate the two options described above.   
Example 1, “Simple Personnel-List” or “Organization-List”:  
In case of these options a screen as given in Figure 32 will open and a button 
“Add Person” or “Add Organization” will appear.  
If these buttons are clicked, another dialog opens displaying all individuals or 
organizations, which are stored in the ObTiMA database.  Any person or 
organization can be selected by a mouse click and will be added to the list. Figure 
32 illustrates such a list already populated with two scientists. The order of the 
entries can be changed by using the up and down arrow buttons in the option column 
(Figure 32 (1)) and entries can easily be removed from the list by clicking the delete 
button (Figure 32 (2)). If additional scientists or organizations become involved into 
the study, they must be added via the ObTiMA administration panel8. Roles and 
responsibilities can be defined in the input field “Title/Function” (Figure 32 (3)) by 
typing in any responsibility, in this example “Chairman” and “Investigator”.  
 
 
                                            
8 ObTiMA administration panel is a tool of the main program ObTiMA. It was given and is not part of 
this paper. 
Figure 32: Input Mask of the Simple Personnel-List 
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Example 2, “Personnel-List” or “Sponsor-List” 
Utilizing the “Personnel-List“ or “Sponsor-List” several individuals can be assigned 
to one single responsibility. By using the “Add new Group” (Figure 33 (1)) an empty 
frame is generated (Figure 33 (2)). Now any responsibility can be typed into the field 
“Title/Function” and allocated individuals can be selected in the ObTiMA 
administration panel. There is no limitation by the software in terms to the number 
of functions as well as number of individuals assigned to one function. It is feasible 
as well to assign one individual to several functions. 
If the input mask of the Personnel-Paragraph is completed, a preview of the printout 
will be displayed by use of the associated button (Figure 30 (5)). 
If ObTiMA does not offer a complete set of personal information, the corresponding 
fields in the generated lists will remain blank. To get visibility of missing data the 
“Hide empty Fields” checkbox (Figure 30 (6)) must not be marked. As result 
wildcards are displayed replacing missing data.  If the missing piece of information 
is entered at a later stage into the ObTiMA database, the data will automatically be 
Figure 33: Input Mask of the Personnel-List 
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transferred into the “Personnel Paragraph” and appear in the printout. There is no 
user action needed to initiate this activity. 
Another feature which needs explanation is the “Use Headline” option (Figure 
30 (7)). If a check is set in this field a headline will be generated to structure the 
protocol. This feature is not unique for the Personal-Paragraph, it is available in the 
Amendment-Paragraph and the Table of Contents-Paragraph as well. 
 Personnel-Text-Paragraph Conversion 
The MasterProtocol-Editor supports conversion from the Personnel- to the Text-
Paragraph and vice versa. This is most helpful to customize a Personnel-List 
generated by the Personal-Paragraph. The conversions can be initiated in the 
“Quick Settings Menu” located in the editor space (Figure 20 (9)) by use of the 
“Convert to Text-Paragraph” option. 
It is important to know that there are some limitations with regard to the converted 
paragraph. The content of the Text-Paragraph will remain unchanged, even if data 
in the ObTiMA database are altered, whereas the original Personnel-Paragraph 
updates the content automatically. In case the Text-Paragraph is converted back 
again into a Personnel-Paragraph, all changes made in the Text-Paragraph will get 
lost and the original Personnel-Paragraph will be reestablished again.  
Contrary to the process described above there is no way to convert a file which 
originally was set up as a Text-Paragraph into a Personnel-Paragraph. This is 
Figure 34: Convert to Text-Paragraph Function 
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caused by the fact, that a Text-Paragraph is designed for highest flexibility and does 
not have a default structure.  
 Type Table of Contents-Paragraph 
The paragraph is indicated by the   icon in the paragraph section (Figure 20 (1)). 
It automatically generates a table of contents as shown in Figure 35. In the standard 
settings, all headlines used in other paragraphs are automatically transferred into 
the table of contents and a hyperlink is established to the corresponding paragraph. 
This option can be disabled for any individual paragraph (4.2.2.3 Customizing the 
Protocol). This is done by default for the introductory chapter.  
 
 
 
 
 
 
 
 
Figure 35: Table of Contents, PDF view, automatically generated 
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The user interface of the Table of Contents-Paragraph is shown in Figure 36. 
The appearance of the table of contents is determined by the setting options (Figure 
36 (1)): 
 Tab Leader: Several options as continuous lines, dotted lines and others. 
 Levels: Number of sub-headlines included in the table of contents. 
 Show Page Count: If disabled, page count will be skipped. 
 Page Count right-aligned: See Figure 37 
 Link Table of Contents with Document Headlines: If this option is selected 
headlines in the table of contents will be highlighted in blue and provide a 
hyperlink to the corresponding chapter in the document. 
 Use Headline: See 4.2.2.1.3.2 User Interface of the Personnel-Paragraph 
 Preview: Preview view of the PDF printout. 
Figure 36: User Interface of the Table of Contents 
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 Type Amendment-Paragraph 
Once all study specific data are entered and the protocol is completed for the first 
time, the actual status is frozen as version one. This and all other consecutive 
versions are saved as secured read only files in the ObTiMA database. There is a 
unique consecutive number allocated to each of the files. This cannot be altered by 
the user. If a new version is generated all changes with regard to the previous 
version are documented. Changes are classified into “substantial” and “non-
substantial”. A “substantial” change affects execution and evaluation of the study 
results so significant that protocols must be reapproved by the authority. “Non-
substantial” changes, for example correction of typos and formatting are less critical. 
Both type of changes impact the version number. In case of non-substantial the 
version number will be extended by a character, in case of substantial the version 
number will increase by one. The Amendment-Paragraph keeps track of every 
change. The user has the option to choose any of the versions and make printouts 
of the protocol. The printouts will include a table listing all the changes since version 
one. The position of the table in the printouts is in the same order as the 
Amendment-Paragraph, indicated by the  icon and has been arranged within 
the paragraph section of the MasterProtocol-Editor (Figure 20 (1)). In each protocol 
there is just one Amendment-Paragraph included. 
 
 
 
  
Figure 37: Page Count right-aligned, Option inactive (a), active (b) 
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 User Interface of the Amendment-Paragraph 
The user interface of the Amendment-Paragraph is shown in Figure 38. 
The icons in the navigation bar in the upper frame of the user interface are not 
unique and they have already been explained above. Just the “Create Amendment” 
button (Figure 38 (1)) is specific to this paragraph. The corresponding functionality 
will be explained in the next chapter.  
The preview (Figure 38 (2)) displays the PDF view of the amendment table. Core of 
the screen is the amendment listing (Figure 38 (3)). This table displays all 
amendments and each row represents one of these. The Amendment number is 
given in the first column (Figure 38 (4)). Only amendments resulting from major 
protocol changes are indicated as “substantial amendment” and carry a number. 
”Non-substantial” amendments have no amendment number. The second column 
(Figure 38 (5)) provides date and time of amendment creation. As explained above, 
every new amendment triggers a new protocol version. This is characterized by the 
protocol version number (Figure 38 (6)). It is generated in accordance to the SIOPE 
guidelines. The next column (Figure 38 (7)) marks the type of change. Beside 
substantial and non-substantial there is one unique type indicated as “auto 
generated” in the first row of the table. It has been set up by the MasterProtocol-
Wizard on completion and it does not carry any number. This document represents 
the SIOPE guideline structure and it just includes basic trial data. It can serve as a 
Figure 38: User Interface of the Amendment-Paragraph 
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backup for clinical study protocol generation in case some errors have occurred 
during the later steps of protocol generation. This document is only listed on the 
screen but it will not be included in the PDF printout of the amendment history. 
The text, given in the next column (Figure 38 (8)) characterizes the amendment.  
Every protocol indicated in the amendment list is frozen. By clicking on the options 
button (Figure 38 (9)) a frozen document can be accessed and printed out, but it 
cannot be altered.  
The PDF settings section has been already described in chapter 4.2.2.1.3.2 User 
Interface of the Personnel-Paragraph. 
 Amendment Generation   
A new amendment can be generated at any time by use of the “Create Amendment” 
button (Figure 38 (1)). The dialog as shown in Figure 39 will appear. 
Figure 39: Dialog for creating new Amendments 
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Under “Type of Amendment” (Figure 39 (1)) the user can select “Substantial 
Amendment” or “Non-substantial Amendment” to characterize the changes with 
regard to the previous version. The amendment number (Figure 39 (2)), the protocol 
version (Figure 39 (3)) and date (Figure 39 (4)) are automatically generated by the 
program. Different to the “Amendment Number” the auto generated settings (Figure 
39 (3), (4)) can be overwritten by the user. However it is recommended to keep the 
default. The summary box (Figure 39 (5)) should be used for a brief characterization 
of the changes with regard to the previous version. By use of the “Create 
Amendment” button (Figure 39 (6)) all paragraphs are merged into a PDF file and 
the version of the new amendment is frozen. As there are plenty of operations 
carried out it the background, this step might take a while.  
4.2.2.2 Folders  
The Folders displayed in the menu section of the MasterProtocol-Editor (Figure 20 
(1)) are a measure to increase clarity of the paragraph section. A folder may include 
one or several paragraphs. They can be identified by a specific icon . Folders are 
a measure to increase clarity of the paragraph section. During creation of the PDF 
printout, the paragraphs will be extracted from the folders and included into the 
protocol at the position of the folder. It is not indicated in the final printout if a 
paragraph has been stored in a folder before.   
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4.2.2.3 Customizing the Protocol  
Number and structure of paragraphs and folders in the standard protocol generated 
by the MasterProtocol-Wizard are arranged in accordance to the SIOPE guidelines.  
 
To obtain standardization this should not be modified. In rare cases however it might 
be advantageous to make some adoptions to meet requirements of a specific study. 
That is why the editor offers the option to edit, move or delete paragraphs and 
folders. In addition new paragraphs and folders can be created. This can be done 
by selecting any paragraph or folder with the right mouse button from the paragraph 
section (Figure 20 (1)) of the MasterProtocol-Editor. Following the selection a 
context menu (Figure 40) will open. 
 Move and delete Paragraph 
By use of the “Move Paragraph” option of the “Paragraph/Folder” context menu, a 
paragraph/folder can be shifted up- or downwards. Delete paragraph/folder erases 
the selected item. 
Figure 40: Paragraph/Folder Context Menu of the MasterProtocol-Editor 
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 Create new Paragraph 
By clicking “Create new Paragraph” another window will open. Now the 
characteristics of the new paragraph can be specified (Figure 41).  
 Type: A drop down menu offers the selection of the 5 paragraph types 
(4.2.2.1 Types of paragraphs). 
 Paragraph Name: The name can freely be chosen, but it should be 
characteristic. 
 Page Break: A forced page break can be inserted either before or after the 
paragraph. 
 Table of Contents: If selected, the headline of the paragraph will be included 
into the table of content. 
 Translation: If the paragraph should only appear in one language and should 
not be included into protocols of different languages this checkbox must be 
activated (4.2.3 Internationalization). 
 Paragraph Position: The new paragraph can be inserted either before or 
after the paragraph by which the context menu was opened. If a folder was 
selected instead, a further option is offered. Here it can be determined if the 
new paragraph will be inserted before, after or in the selected folder.  
Figure 41: Dialog for Creating new Paragraphs 
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 Edit Paragraph Settings 
Paragraphs already existing can be edited using the dialog given in Figure 42. This 
dialog can be accessed through the Paragraph/Folder Context Menu (Figure 40) of 
the MasterProtocol-Editor by clicking the option “Edit Paragraph Settings”. Within 
this dialog, all parameters of the paragraph can be determined. However, there is 
one exception. Once the type of the paragraph has been chosen in the 
MasterProtocol-Editor, it cannot be altered at a later stage. The information panel of 
this dialog will be explained later (4.2.3 Internationalization). 
Figure 42: Dialog for Editing the Paragraph Settings 
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 Create new Folders 
A new folder can be created by use of the dialog given in Figure 43. This dialog can 
be opened with the option “Create Folder” in Paragraph/Folder Context Menu 
(Figure 40) of the MasterProtocol-Editor. 
 Name: Name of the new folder. 
 Folder Position: The new folder can be inserted either before or behind the 
paragraph/folder which was selected to open the dialog.  
 Internationalization 
If a multicenter study is performed in several countries, there is a need to provide 
some parts or even the complete protocol in two or several languages. This is 
particularly mandatory for the Informed Consent  as each study participant must 
precisely understand and agree to the medical trial and the associated risks. To 
avoid any misunderstanding this document must be provided in the mother tongue 
of the individuals affected.  
With the MasterProtocol-Editor some paragraphs or the complete protocol can be 
translated into several languages. The language which was selected while the 
MasterProtocol-Wizard was executed the first time is the default language. The 
corresponding document is stored as master document. It will remain as default and 
will not be altered if some paragraphs or the complete document is translated into 
another language. Paragraphs in other language are stored in addition and during 
Figure 43: Dialog for Creating new Folders 
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printout multi or single language protocols can be chosen. To translate a document, 
the MasterProtocol-Editor needs to be set to the desired language. This can be done 
in the quick settings menu of the MasterProtocol-Editor (Figure 20 (9)) by selecting 
the option “Change Language”. 
 
  
The “Change Language” dialog (Figure 44) offers a drop down menu, displaying all 
available languages. The editor can be set back to the default language by clicking 
the “Default Language” button. 
If a novel language is selected from the menu, the paragraph section as given in 
Figure 45 will change its appearance.  
Paragraphs which cannot be translated are still displayed in blue letters. Among the 
non-translatable paragraphs there are the Amendment-Paragraph and the Table of 
Contents-Paragraph. All paragraphs which can be translated are displayed in grey 
letters. The translation is done in the “Paragraph Settings Dialog” (Figure 42) using 
the „Translate” button. As a result a copy of the already existing paragraph will be 
generated serving as basis for the translation. Once a document has been 
Figure 44: Quick setting Menu, Change Language 
Figure 45: Paragraph Section: Default language English (a), Editor set to German (b), Editor 
set to German, paragraph “Important Notice” translated into German orange highlighted (c) 
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translated by a user it can be stored and is immediately available for protocol 
generation. It is important to know, that the original paragraph will remain completely 
unchanged. The translated paragraph can be identified by the orange letters in the 
paragraph section of the MasterProtocol-Editor (Figure 45 (c)). If a PDF-protocol is 
printed out in a different than the default language, all paragraphs that have not 
been translated will be included into the printout in the default language. As a result 
there might be a German Protocol with some English chapters included. As an 
example this might be required for the Informed Consent of a German trial including 
some native English-speaking individuals.  
 Overview over Paragraphs in various Languages 
An overview over all paragraphs and the corresponding languages is displayed on 
the Welcome screen of the MasterProtocol-Editor. It appears once the editor is 
opened but it can be accessed during an editor session at any time by usage of the 
navigation bar. 
The information page is illustrated in Figure 46. Under “Protocol Statistics”, all 
paragraphs in use are listed. On the right side of the screen there are the utilized 
languages are given. In the picture (Figure 46) the editor is set to English. By clicking 
the “Change Language” button (Figure 46 (1)) it will switch to German. There-
after the language is set to German and the “Change Language” button will 
appear behind English. 
Figure 46: MasterProtocol-Editor Information Page 
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More information concerning a specific paragraph is available by selecting the 
paragraph with the right mouse button and clicking “Edit Paragraph Settings” 
(4.2.2.3.3 Edit Paragraph Settings). As a result the “Paragraph Settings” dialog 
given in Figure 42 will appear. Figure 47 displays an enlarged section of this dialog 
featuring the “Paragraph Translations” table. 
As indicated by the yellow highlighted row, the current language of the editor is 
German. 
 Independent: If a paragraph was set up in the “Dialog for creating a new 
Paragraph” (Figure 41) using the option “Only for current Translation” this 
paragraph will only be available in the language it was created. In this case, 
a checkmark will become visible in the column “Independent” and there will 
be no option to translate this paragraph into any other language.  
 Translatable: Paragraph in the default language, it can be translated. 
 Translated: Paragraphs already translated. 
 Converted to Text: If the paragraph has been converted into a 
Text-Paragraph a checkmark appears in this box. If the paragraph can not 
be converted “Not Supported” is displayed instead. 
 Options 
o Change Language : If used, the editor is switched to the 
language of the selected paragraph. The dialog will close thereafter 
and the paragraph is displayed in the editor space of the 
MasterProtocol-Editor (Figure 20 (3)).  
o Delete (Cross) : Deletes the paragraph. If a paragraph in the 
default language is selected all translations will be deleted as well. In 
contrast, deletion of a translated paragraph will not affect the other 
language files. 
Figure 47: Enlarged section of the Paragraph Settings Dialog (Figure 42), indicating 
the utilized languages. 
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 PDF Export 
Each finished protocol version can be downloaded to a local computer by authorized 
users. The download function is accessible via the options menu of the 
MasterProtocol-Editor (Figure 20 (6)). Once the options menu has opened, the 
“Export Protocol” button (Figure 22) becomes available. When using this button the 
“Export Protocol” page will open (Figure 48). 
In the drop down menu “Select Version” (Figure 48 (1)) all available protocol 
versions are listed. Among these all previous finalized versions and the currently 
processed protocol are archived.  
If several languages are available, these are given in the “Select Language” (Figure 
48 (2)) panel and the desired one can be selected. Details concerning multi 
language protocols see 4.2.3 Internationalization. 
Before starting the download a preview of the selected PDF protocol will appear in 
the “Preview” section of the screen (Figure 48 (3)). If the protocol meets all 
expectations, the download can be initiated by the “Download” button (Figure 
48 (4)). As a final step any location on the local drive can be selected to store the 
protocol. 
Figure 48: Export Protocol Page 
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 Editor Settings  
Appearance of the MasterProtocol-Editor and the PDF printout are defined in a 
menu, which is accessible via the “Editor Options Menu” (Figure 20 (6)) by clicking 
the option “Settings” in the option menu (Figure 22). 
The user interface (Figure 49) is similar in structure to the input mask of the 
MasterProtocol-Editor. On the left hand side there is a menu listing all potential 
options.  The first three entries (“General”, “Language”, “Editor Settings”) affect the 
editor, all other impact layout of the PDF. If one of the keywords is selected, all 
potential settings will appear on the right hand side of the screen. By using the 
“Back” button in the very right hand upper corner of the screen, the window will close 
and the user is back again in the MasterProtocol-Editor. It is important to know, that 
any entries in this input mask will get lost unless they have been confirmed (saved) 
by the “Store File” icon . 
4.2.6.1 General  
The input mask “General” (Figure 49) has two purposes. One enables saving of the 
current work status, the other is designed to delete a protocol. Via “Autosave”, 
frequency of background saving can be configured. To avoid data loss that might 
occur by issues with the internet connection, it is recommended to select rather 
narrow intervals. The default is 5 min.  
Figure 49: MasterProtocol-Editor Settings, General Tab opened 
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The “Delete Protocol” only works with administrator rights. It completely deletes all 
protocol versions, including the default one. This command will be very rarely 
needed, it is predominately intended for developmental purposes. 
4.2.6.2 Language  
The “Language” input mask (Figure 50) displays the default protocol language and 
enables a switch between the different languages available. 
The default language of the study protocol has been set in the MasterProtocol-
Wizard at the very beginning of protocol creation. This setting is indicated as 
“Default Language” in the screen given above. If a different language is selected 
with “Edit Language”, any paragraph, which is generated by the Editor thereafter, 
will be saved in the selected language. The new file might be a translation of one of 
the paragraphs already existing, or a newly generated paragraph. In case of 
translation the new file will be saved as additional document, but the original file will 
be kept and not overwritten. Utilizing the “Export Protocol” page (4.2.5 PDF Export), 
the user can make a selection before download of the study protocol, to have it just 
in the default language or with all the translated paragraphs being included.  
 
4.2.6.3 Editor  
The input mask “Editor” of the editor settings is used to customize appearance of 
the display screen.  
Figure 50: MasterProtocol-Editor Settings, Language Tab opened 
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Under “Layout” (Figure 51) it can be selected if two or three columns will be 
displayed. If the option two columns is set,only the paragraph section and the editor 
space of the MasterProtocol-Editor is displayed. If three columns are selected, the 
third column will appear at the right side of the editor screen, showing the help menu 
(Figure 20 (2)). 
The “Show Page Breaks” option defines if the printout will utilize a new page or 
continue on the same one for any single paragraph (4.2.2.3 Customizing the 
Protocol). The page breaks are indicated on the computer screen by underlining the 
corresponding paragraphs. Figure 52 shows an example for the activated “Show 
Page Breaks” option on the right side and the disabled option on the left side (default 
value). 
 
 
 
 
  
Figure 51: MasterProtocol-Editor Settings, Editor Tab opened 
Figure 52: Show Page Breaks, deactivated (a), activated (b) 
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4.2.6.4 PDF Style 
Appearance of the PDF can be determined by three input screens, “Page”, “Header” 
and “Footer”.  
 Page Style  
This impacts the protocol layout with regards to margins, orientation of the pages 
and bookmarks. 
 Page Margin: This drop down menu offers several predefined page margins. 
If none of these meets expectations, page margins can be individualized by 
overwriting the figures in the dropdown boxes. 
 Mirrored Page Margins: Intended purpose of this option is the generation of 
protocol pages suitable for booklets. If activated by the check mark, “Inner 
Margin” and “Outer Margin” appear and recommendations for the optimal 
values are displayed. 
 Orientation: Portrait or Landscape format. 
 Bookmarks: If “Create Bookmarks of Headlines” is selected, the editor will 
utilize the headlines present in the paragraphs to generate bookmarks within 
the exported PDF. With the option “Headline Level”, number of sub headlines 
can be determined. 
Figure 53: MasterProtocol-Editor Settings, Page Tab opened 
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 Header/Footer 
The Header and the Footer input masks are set up similar and most of the options 
are self-explanatory. 
Just the following needs explanation (Figure 54): 
 Different Header for First Page: If the first page of the document should not 
carry any or a different header, this option needs to be activated. If this is 
done, a further dialog opens to enable individual settings for the first page. 
 Distinguish Even and Odd Pages: If the single pages will be combined into 
a booklet, location of the header can be separately set for even and odd 
pages.  
 
 
  
Figure 54: MasterProtocol-Editor Settings, Header Tab opened 
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4.3 MasterProtocol-Helpcenter 
The MasterProtocol-Helpcenter can be called up in the MasterProtocol-Wizard as 
well as in the MasterProtocol-Editor at any time. It provides extended help for 
program handling, it offers further readings concerning regulatory background and 
there are hyperlinks given for internet access to the applicable guidelines and 
regulations. The start screen of the Helpcenter is displayed in Figure 55. 
 
Figure 55 Start Screen of the MasterProtocol-Helpcenter 
All available help topics are listed in the left column of the screen. The online help 
for any of these topics can be called up by a mouse click. The help text will appear 
on the right hand side of the screen. In addition there is a search box. Free text can 
be entered and the program will perform an associative search displaying the best 
matches. Navigation through the pages is enabled by the “Previous” and “Next” 
buttons. Utilizing the “Back” button the program will jump back to the screen from 
which the Helpcenter has been approached. 
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5 Discussion 
As discussed in this dissertation many study protocols are not properly elaborated 
and not all publications meet the required standards. This is why there have been 
many attempts and initiatives to improve accuracy and completeness of protocols 
and study reports. It has been shown that significant improvement has been 
achieved throughout the recent decades. However it cannot be ignored that even 
today there are still major deficiencies evident. It has been proven that these issues 
result in misinterpretation of scientific results, increased cost and additional 
workload (2.2 Necessity of Study Protocols). Therefore it is important to take further 
actions to eliminate the remaining deficiencies. Hence it seems all the more 
surprising that only very little use has been made to utilize modern IT software.  
 
5.1 Solution 
To evaluate the basic question of this work „ Are there any means to utilize IT to 
generate a perfect study protocol”, determining factors of significance and potential 
impact parameters have been reviewed. The most important of these are: 
 Supporting materials and tools already available (guidelines, protocol 
templates, toolkits) 
 Identification of communalities and differences among international 
guidelines and regulations 
 Review of scientific literature to understand major protocol gaps and study 
impact 
 Framework for programming: 
o Identification of a suitable protocol template  
o Usability for IT implementation of supporting materials already 
available 
o Potential boundaries to utilize a standard protocol template for 
international use in various jurisdictions 
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o Multi language for the complete protocol or single paragraphs 
o Single and multicenter studies  
o Parallel work of several scientists in various locations 
o Failure tolerance through transparent user guidance 
o Extendible and service friendly program architecture 
o Audit trail and version control of the protocols 
o Data protection 
o Minimization of IT cost 
As a starting point for program design, many protocols of clinical studies were 
checked and the conclusions drawn were elaborated by discussions with IT 
specialists and experienced investigators. Good advice was received and once the 
first program modules were set up they were put up as a basis for discussion on a 
medical congress. During this event there was a lively debate and many expert 
provided optimization ideas. Among those there was the proposal for drag and drop 
import of pictures, the functionality to hide help screens by more advanced users 
and many hints to optimize the intuitive usability of the MasterProtocol-Wizard.  
As research became more and more international and conclusions drawn from 
clinical trials had to support multinational drug registrations, international guidelines 
were developed post Second World War. This was reflected by the Declaration of 
Helsinki of 1964 and the ICH GCP Guidelines dated from 1996. Specifically the latter 
was a milestone as the first time the USA, Europe, Australia and Japan agreed on 
rather comprehensive guidelines in a mutual recognition process [9], [10]. It took a 
while until these guidelines were transferred into national law, which was done for 
the first time by the US in 1974 [11]. Although transcriptions differ among the various 
nations, a valid basis for international protocol acceptance has been set. Never-
theless there are discrepancies among the diverse transcriptions. The whole area 
is still in a constant move and many of the regulations and guidelines still lack of 
clarity or are difficult to access [26]. Therefore selection of a suitable protocol 
template was one of the crucial points of this work. The high level of harmonization 
reached within the European Union has simplified this task and the SIOPE template 
was selected as basis for program development. This template is in full accordance 
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to the ICH GMP Guideline. It is in full compliance with all rules and regulations of 
the EU and it completely meets Germans provisions. In addition the SIOPE template 
is highly elaborated with regards wording and format of the protocol pages. It also 
provides standard text blocks and only study specific key words need to be inserted 
(For example see Appendix 6.4 SIOPE-TEMPLATE, Chapter 11.1 Site Set-up and 
Initiation). To ensure that all local (German) legal provisions are met it was verified 
that transcription of the EU guidelines into national laws had been progressed to a 
point that no additions needed to be made to the SIOPE templates. 
 
Initial analyses revealed issues regarding a completely standalone program. It 
would have been very costly and extremely time consuming to set it up from the 
scratch and code a complete program environment. Therefore the MasterProtocol-
Creator was designed as extension of the study administration program ObTiMA 
[76]. ObTiMA already contains a data base with a large amount of study data, 
provides access control and personal data protection. Due to the modular design of 
ObTiMA and the strong support of its developer’s team, the MasterProtocol-Creator 
could seamlessly be integrated. Existing infrastructure could be utilized and 
development efforts could be kept within the bounds of what is reasonably possible 
within the boundaries of doctoral theses without jeopardizing functionality and 
usability of the program.  
The MasterProtocol-Creator consists of three parts. These are the MasterProtocol-
Wizard, the MasterProtocol-Editor and the MasterProtocol-Helpcenter. The 
complete software architecture is structured modularity through to the lowest level 
of program code. This provides a transparent and easy to maintain program 
structure and bug fixing could be reduced to a minimum. As important future 
program extensions can easily be attached and the program can be adapted to 
changes in the underlying legislative or to new user requirements. 
The modular approach was not only applied to the program code, but to the structure 
of the study protocol as well. These consist of independent modules, called 
paragraphs. Each of the paragraphs contains one section of the SIOPE template. 
The paragraphs are merged to a protocol just before printing. This enables study 
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protocols which are easy to customize. With very little efforts and without coding a 
user can add new and modify or delete existing paragraphs.  
It cannot be expected that physicians and other personnel involved into a clinical 
study are trained computer experts or highly educated with regard to the relatively 
complex legal requirements. That is why the program provides a graphical user 
interface. The required data are clearly defined in the input masks. A user just needs 
to enter the data into input fields and he is guided step by step through to the 
complete dataset needed for protocol generation. Each input mask includes 
explanatory text about the data and data format and at any time a user has access 
to a highly elaborated help system. This includes further information and hyperlinks 
to helpful websites. Among these there are the SIOPE-Template [41], the ICH 
Guideline [12], the EudraCT documents [30] and many more. 
 
At the end of the process, the MasterProtocol-Creator automatically merges the 
single paragraphs into a complete protocol. This is done without any user 
involvement. The final PDF protocol can be downloaded and printed out by 
authorized users. Before downloading, a user can utilize the preview function to 
ensure that expectations are met.  
 
Clinical studies might be performed across several countries or might include 
patients of different nationalities. Sponsors, scientists and other personal must 
completely understand the study protocol and precisely act in accordance therewith 
and therefore it is helpful to have the document in the mother tongue. For the 
„Informed Consent“ it could be useful that this document is accessible in native 
language of the individuals. To meet these requirements the MasterProtocol-
Creator can manage single items or even complete protocols in several languages.  
 
The MasterProtocol-Creator is web based. To create a study protocol a user just 
needs a standard computer, a common web browser and permanent internet 
access. He does not need to purchase a specific software package, he has not to 
take care for software updates and he does not need any hardware extensions.  
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Since the MasterProtocol-Creator is linked to ObTiMA it gets many study data 
transferred from the database. This avoids redundant data entry and once ObTiMA 
data are updated or amended by a user they are immediately available for protocol 
generation by all other users as well. The independent paragraphs and the web 
based architecture of the MasterProtocol-Creator enables multicenter, parallel work. 
Several scientists in different locations can access the MasterProtocol-Creator 
simultaneously. Independent of the number of individuals working with a document, 
there is just one valid version of the protocol. Once a protocol is finalized a version 
number is attached and the protocol is stored. By a numbering system in 
accordance to SIOPE and an auto-generated amendment table, seamless audit trail 
and version control is ensured. 
All data remain on the server and are only accessible by the MasterProtocol-
Creator. Data transfer is secured by encryption of the data and ObTiMA provides a 
highly elaborated access control. Only users with appropriate credentials can 
access data to a predefined extent. These measures meet all requirements of 
personal data protection.  
The objective of cost minimization has been completely met by utilization of royalty 
free open source software. These have been the UNIX operating system, the 
Tomcat webserver, the PostgreSQL database and some others. Another 
contributing factor was the selection of Java for program coding. This highly flexible 
computer language is very widely used. There is a worldwide community willingly 
provided support and many Java royal free toolkits simplified programming.   
5.2 Programm Advantages 
The MasterProtocol-Creator provides unique capabilities that have not been 
achieved before and is unknown for any other software dealing with clinical trials. 
The most important are: 
 High data security by centralized data storage, access control and transfer of 
encrypted patients data 
 Parallel access by several users at different locations 
 95 
 
 Multilingual study protocols 
 One single set of data at any time 
 Central version control and audit trail 
 Global access to electronic protocol in PDF format and electronic keyword 
screening capability  
 Cost minimization 
 Simple adaptation to new requirements 
 Failure tolerant graphical user interface and elaborated help system 
 No need to become acquainted in detail with complex guidelines 
 Avoidance of vague protocols and gaps in study documentation 
 
 
5.3 Comparison to other Programs available 
As shown in this work, until now several attempts were made to improve quality and 
accuracy of clinical study protocols by means of IT tools. As result of our reviews 
there are three different groups of IT tools available. Each of these focuses on 
specific aspects but none of these completely supports protocol generation. 
Presently available there are either customized text editors, knowledge databases 
or tools, which translate a protocol into a machine readable format. Most advanced 
and comprehensive are the CT Toolkit, the CDISC Protocol Wizard Demonstration 
Tool and the SOWG Protocol Reviewing System.  
The CT Toolkit (2.4.5.1 CT Toolkit) [63] is one example for a knowledge database. 
It provides plenty of information and improves transparency of study flow. However, 
there is no direct support for drawing up the protocol. Although the applicable 
guidelines are referenced, the user is left alone with the adequate transcription in a 
protocol.  
In contrast the PRM (Protocol Representation Model) issued by CDISC [66] 
supports completeness and machine readability of trial documentation. However a 
user can only access an online demonstration tool, which just provides 30 protocol 
core items out of the original approximately 300 item model. A PDF list with these 
 96 
 
30 items can be printed out. This can serve as a checklist, but a valid study protocol 
is not generated. 
Finally the SWOG Protocol Reviewing System [68] makes an online Editor available 
and enables parallel access by several users. In addition there is a highly complex 
review system integrated through which authors can communicate to each other 
and improve a drafted protocol. There have been field trials made by the SWOG 
group with this program but it did not prevail, as there were some deficiencies. The 
review system has been regarded as too technical and time consuming for some 
users and the word processor just provides very basic functionality. This fact and 
the lack of a predefined protocol template make it difficult to prepare a clear and 
transparent protocol. Major deficiencies however are a missing step by step user 
guidance and the unavailability of templates which exclude unexperienced scientists 
from protocol generation and bears the risk of incomplete protocols. Unlike the 
MasterProtocol-Creator it does not offer user training and there are no help screens 
or comprehensive online help links available as given by the MasterProtocol-
Helpcenter. 
In a study conducted by Caroline Barnes et al [24], it was shown that even limited 
electronic support has the potential to significantly improve quality of study 
protocols. The MasterProtocol-Creator is building on these findings and in extension 
to the previous attempts the MasterProtocol-Creator consequently utilizes web 
based IT to seamlessly guide a user step by step through the complete process of 
protocol generation. The failure tolerant graphical user interface and comprehensive 
online help enable even less experienced users to generate a state of the art study 
protocol. It can be expected that the MasterProtocol-Creator closes the current gap 
and has the potential to significantly improve quality of study protocol and validity of 
clinical trials. 
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5.4 Limitations  
One limitation of the program results from the basic design. The MasterProtocol-
Creator is not a standalone program. It is seamlessly integrated into ObTiMA. It 
exchanges data and utilizes data protection mechanisms of the database. Thus it 
cannot be used as a single-station system. It requires permanent internet access 
and user registration for ObTiMA. 
The current version of the MasterProtocol-Creator is based on the SIOPE template. 
By design it is customized for pediatric oncology research. Even though the program 
enables easy adaptation to various medical trial areas, this requires an engagement 
of the study authors with the guidelines and templates applicable to the specific 
research area. To simplify protocol generation it might be helpful for very 
inexperienced users to add additional or alternative templates for other research 
areas to the MasterProtocol-Creator.  
To further develop the MasterProtocol-Creator one might think about cooperation 
with one of the well-known institutions as the SPIRIT Statement Group [50]. By 
cooperation with organizations being at the forefront of study evolution the 
MasterProtocol-Creator would not only be advertised to a broader user group but it 
could always be kept up to date by getting input from a highly experienced scientist 
community. 
Another idea is the integration of the SPIRIT statement or the RPM of CDISC [66] 
into the MasterProtocol-Creator. It is commendable to extend the MasterProtocol-
Creator in a way that a user can perform a check of the finalized protocol with help 
of these checklists. By marking key phrases in the study protocol a core document 
as proposed by the PRM could be generated automatically. This might simplify 
customization of the MasterProtocol-Creator to research areas with unique 
requirements. A checklist would not only ensure that no important detail is missed, 
but it would support standardization and simplify electronic screening of the clinical 
protocols.  
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Finally the MasterProtocol-Creator enables parallel work of several scientists but it 
does not have a reviewing system integrated unlike the SWOG Protocol Reviewing 
System. Authors need to share their ideas and comments by mail or phone. 
Although this does not affect version control, a clearly arranged, simple to handle 
and fully integrated reviewing system could foster discussions and knowledge 
sharing among the authors.   
5.5 Perspectives 
As the software development, testing and bug fixing of the MasterProtocol-Creator 
is completed, the program can be applied to a clinical study. This is now done with 
the next SIOP nephroblastoma trial, called UMBRELLA. This is a multicenter, 
multinational prospective trial that will include all European countries, in addition 
Brazil, Argentina, Uruguay, Russia, Egypt, Hong Kong, and centers in Japan, 
Australia and New Zealand. 
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